UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement | |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☒ | Definitive Proxy Statement | |
☐ | Definitive Additional Materials | |
☐ | Soliciting Material Pursuant to §240.14a-12 |
Ambarella, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. | |||
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
(1) | Title of each class of securities to which transaction applies:
| |||
(2) | Aggregate number of securities to which transaction applies:
| |||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
(4) | Proposed maximum aggregate value of transaction:
| |||
(5) | Total fee paid:
| |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
(1) | Amount previously paid:
| |||
(2) | Form, Schedule or Registration Statement No.:
| |||
(3) | Filing party:
| |||
(4) | Date Filed:
|
AMBARELLA, INC.
3101 JAY STREET
SANTA CLARA, CA 95054
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
To Be Held On June 6, 2018
Dear Shareholder:
NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders of Ambarella, Inc., a Cayman Islands company, will be held on Wednesday, June 6, 2018, at 9:00 a.m. Pacific Time at 3101 Jay Street, Santa Clara, CA 95054 for the following purposes:
1. | To elect the three nominees for Class III director named herein to hold office until the 2021 Annual Meeting of Shareholders. |
2. | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Ambarella, Inc. for the fiscal year ending January 31, 2019. |
3. | To approve, on an advisory basis, executive compensation. |
4. | To conduct any other business properly brought before the meeting. |
These items of business are more fully described in the Proxy Statement, which is available at www.edocumentview.com/AMBA. This notice, the Notice of Internet Availability, the Proxy Statement for our Annual Meeting of Shareholders and the 2018 Annual Report and form of proxy are being made available to shareholders on or about April 27, 2018. We are providing access to our proxy materials over the Internet under the rules and regulations adopted by the U.S. Securities and Exchange Commission.
The record date for the Annual Meeting is April 12, 2018. Only shareholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. We are not aware of any other business to come before the Annual Meeting. You may vote over the Internet, by telephone or by mailing a proxy card. Voting over the Internet, by telephone or by written proxy will ensure your representation at the Annual Meeting if you do not attend in person. Please review the instructions on the proxy card regarding each of these voting options. The Proxy Statement explains proxy voting and the matters to be voted on in more detail. We look forward to your attendance at the Annual Meeting.
By Order of the Board of Directors
Michael Morehead
General Counsel and Secretary
Santa Clara, California
April 27, 2018
You are cordially invited to attend the meeting in person. Your vote is important. Whether or not you expect to attend the meeting, please vote your shares as instructed in the Notice of Internet Availability, which is being mailed to you on April 27, 2018, as promptly as possible to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.
Page | ||||
1 | ||||
1 | ||||
1 | ||||
1 | ||||
2 | ||||
2 | ||||
3 | ||||
3 | ||||
4 | ||||
4 | ||||
4 | ||||
5 | ||||
5 | ||||
6 | ||||
9 | ||||
Information Regarding the Board of Directors and Corporate Governance |
10 | |||
10 | ||||
10 | ||||
10 | ||||
10 | ||||
12 | ||||
12 | ||||
13 | ||||
14 | ||||
14 | ||||
15 | ||||
Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm |
17 | |||
17 | ||||
18 | ||||
18 | ||||
19 | ||||
20 | ||||
20 | ||||
21 | ||||
22 | ||||
22 | ||||
35 | ||||
36 | ||||
37 | ||||
38 | ||||
39 | ||||
41 | ||||
45 | ||||
46 | ||||
Security Ownership of Certain Beneficial Owners and Management |
47 | |||
48 | ||||
49 | ||||
Shareholder Proposals for the 2019 Annual Meeting of Shareholders |
50 | |||
51 | ||||
51 | ||||
51 |
-i-
Ambarella, Inc.
3101 Jay Street
Santa Clara, CA 95054
PROXY STATEMENT
FOR THE 2018 ANNUAL MEETING OF SHAREHOLDERS
INFORMATION CONCERNING VOTING AND SOLICITATION
In connection with the solicitation of proxies by the Board of Directors of Ambarella, Inc., a Cayman Islands company (the Board), and pursuant to the rules and regulations adopted by the U.S. Securities and Exchange Commission, we are furnishing our proxy materials to shareholders for use at our 2018 Annual Meeting of Shareholders (the Annual Meeting), and any adjournments or postponements thereof. The Annual Meeting will be held on Wednesday, June 6, 2018, at 9:00 a.m. Pacific Time at our offices located at 3101 Jay Street, Santa Clara, CA 95054.
We have mailed the Notice of Internet Availability to all shareholders and beneficial owners of record as of the record date, April 12, 2018. All shareholders will have the ability to access the proxy materials via the Internet, including this Proxy Statement and our 2018 Annual Report to Shareholders for the fiscal year ended January 31, 2018. The Notice of Internet Availability includes information on how to access the proxy materials, how to submit your vote over the Internet, by phone or how to request a paper copy of the proxy materials. This Proxy Statement and our 2018 Annual Report to Shareholders are available at www.edocumentview.com/AMBA. If you are a shareholder of record, you also may view these materials at http://www.envisionreports.com/AMBA.
References to the Company, Ambarella, we, us or our throughout this Proxy Statement mean Ambarella, Inc.
GENERAL INFORMATION ABOUT THE ANNUAL MEETING
Notice of Internet Availability
Instead of mailing a paper copy of our proxy materials, we have provided access to our proxy materials over the Internet, which are available at www.edocumentview.com/AMBA. If you are a shareholder of record, you also may view these materials at http://www.envisionreports.com/AMBA. In accordance with rules and regulations adopted by the U.S. Securities and Exchange Commission, the Notice of Internet Availability has been sent to our shareholders of record and beneficial owners as of the record date, April 12, 2018. The Notice of Internet Availability includes information on how to access the proxy materials, how to submit your vote via the Internet and how to request a paper copy of the proxy materials. By accessing the proxy materials on the Internet or choosing to receive your future proxy materials by email, you will save us the cost of printing and mailing documents to you and will reduce the impact of our annual meeting of shareholders on the environment.
The Board asks you to appoint Feng-Ming (Fermi) Wang, George Laplante and Michael Morehead as your proxy holders to vote your shares at the Annual Meeting. You make this appointment by voting your shares by proxy, as instructed in the Notice of Internet Availability.
If appointed by you, the proxy holders will vote your shares as you direct on the matters described in this Proxy Statement. In the absence of your direction, they will vote your shares as recommended by the Board.
1
Unless you otherwise indicate, you also authorize your proxy holders to vote your shares on any matters not known by the Board at the time this Proxy Statement was made available to shareholders and which may be properly presented for action at the Annual Meeting.
Only shareholders of record at the close of business on April 12, 2018 will be entitled to vote at the Annual Meeting. On this record date, there were 33,475,481 ordinary shares outstanding and entitled to vote. Each holder of ordinary shares is entitled to one vote for each share held as of April 12, 2018. There is no cumulative voting in the election of directors.
Shareholder of Record: Shares Registered in Your Name
If on April 12, 2018, your shares were registered directly in your name with Ambarellas transfer agent, Computershare Trust Company, N.A., then you are a shareholder of record. As a shareholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the meeting, we urge you to vote your shares by proxy over the Internet, by telephone, or by mail as instructed in the Notice of Internet Availability to ensure your vote is counted.
Beneficial Owner: Shares Registered in the Name of a Broker or Bank
If on April 12, 2018, your shares were held not in your name, but rather in an account at a brokerage firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in street name and the Proxy Statement is being forwarded to you by that organization. The organization holding your account is considered to be the shareholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the shareholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent.
You may either vote For the nominees for Class III Director or you may Withhold your vote for the nominees. For each of the other matters to be voted on, you may vote For or Against or abstain from voting.
The procedures for voting are as follows:
Shareholder of Record: Shares Registered in Your Name
If you are a shareholder of record, you may vote in person at the Annual Meeting, vote by proxy over the Internet, by telephone or by mail, as instructed in the Notice of Internet Availability. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already voted by proxy.
| To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. |
| To vote over the telephone, dial toll-free 1-800-652-8683 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the proxy card. Your vote must be received by 11:59 p.m. Eastern Time on June 5, 2018 to be counted. |
| To vote through the Internet, go to http://www.envisionreports.com/AMBA to complete an electronic proxy card. Your vote must be received by 11:59 p.m. Eastern Time on June 5, 2018 to be counted. |
2
| To vote using the proxy card (if you requested paper copies of the proxy materials to be mailed to you), simply complete, sign and date the proxy card and return it promptly in the envelope to be provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. |
Beneficial Owner: Shares Registered in the Name of Broker or Bank
If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should receive the Notice of Internet Availability from that organization rather than from Ambarella. Simply follow the voting instructions in the Notice of Internet Availability to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from your broker, bank, or other agent. Follow the instructions from your broker or bank, or contact your broker or bank to request a proxy form.
There are three matters scheduled for a vote at the Annual Meeting:
| Election of the three (3) directors named as nominees for Class III director in this Proxy Statement to hold office until the 2021 Annual Meeting of Shareholders; |
| Ratification of the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending January 31, 2019; and |
| Approval, on an advisory basis, of executive compensation, as described in this Proxy Statement. |
If you are a shareholder of record and you vote via the Internet, by telephone or return a proxy card by mail, but do not select a voting preference, the persons who are authorized to vote your shares will vote:
| FOR each of the three (3) nominees for Class III director named herein to hold office until the 2021 annual meeting of shareholders; |
| FOR the ratification of the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending January 31, 2019; and |
| FOR the approval, on an advisory basis, of executive compensation, as described in this Proxy Statement. |
If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should follow the voting instructions provided by your broker, bank other agent in order to instruct your broker, bank or other agent how to vote your shares.
Shareholders of record can revoke their proxies at any time before they are exercised in any of three ways:
| by voting in person at the Annual Meeting; |
| by submitting written notice of revocation to the Secretary of the Company prior to the Annual Meeting; or |
| by submitting another properly executed proxy of a later date prior to the Annual Meeting. |
Beneficial owners of shares held in street name must contact their broker, bank or other agent to revoke any prior voting instructions.
3
Directors are elected by a plurality vote, which means that the three (3) nominees for Class III director receiving the most affirmative votes will be elected. All other matters submitted for shareholder approval, including the ratification of the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending January 31, 2019, require the affirmative vote of the majority of shares present in person or represented by proxy and entitled to vote.
A quorum of shareholders is necessary to hold a valid Annual Meeting. A quorum will be present if shareholders holding at least a majority of the outstanding shares entitled to vote are present at the meeting in person or represented by proxy. On the record date, there were 33,475,481 shares outstanding and entitled to vote. As a result, shareholders holding at least 16,737,741 shares will need to be present at the meeting in person or represented by proxy to constitute a quorum. Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) over the Internet, by telephone, by mail or if you attend the Annual Meeting in person. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, then either the chairman of the meeting or the holders of a majority of shares present at the meeting in person or represented by proxy may adjourn the meeting to another date.
Abstentions on any matters are treated as shares present or represented and entitled to vote on that matter and have the same effect as a vote against such matter.
If your shares are held in street name and you do not instruct your broker on how to vote your shares, your broker, in its discretion, may either leave your shares unvoted or vote your shares on routine matters. Only Proposal 2 (ratifying the appointment of our independent registered public accounting firm) is considered a routine matter. Proposal 1 (election of directors) and Proposal 3 (approval of the advisory vote on executive compensation) are not considered routine matters, and without your instruction, your broker cannot vote your shares as to those proposals. If your broker returns a proxy but does not vote your shares, this results in a broker non-vote. Broker non-votes will be counted as present for the purpose of determining a quorum. However, as brokers do not have discretionary authority to vote on Proposal 1 or Proposal 3, broker non-votes will not be counted for the purpose of determining the number of votes cast on Proposal 1 or Proposal 3.
Votes will be counted by the inspector of election appointed for the meeting, who will separately count: with respect to the election of the director, For and Withhold votes and, with respect to other proposals, votes For and Against, abstentions and, if applicable, broker non-votes. Abstentions will be counted towards the vote total for Proposal 2, and will have the same effect as Against votes. Broker non-votes, although counted toward the quorum requirement, will not be counted towards the vote total for any proposal.
Other Matters Brought Before the Meeting
The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.
The Company will pay for the entire cost of soliciting proxies. In addition to these proxy materials, the Companys directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. The Company also may reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.
4
Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that the Company expects to file within four business days after the Annual Meeting. If final voting results are not available in time to file a Form 8-K within four business days after the meeting, the Company intends to file a Form 8-K to publish preliminary results and, within four business days after the final results are known, file an additional Form 8-K to publish the final results.
Important Notice Regarding Availability of Proxy Materials
This Proxy Statement and our 2018 Annual Report to Shareholders are available at www.edocumentview.com/AMBA. Please promptly vote your shares as instructed in the Notice of Internet Availability. This will not limit your rights to attend or vote at the Annual Meeting.
5
ELECTION OF CLASS III DIRECTORS
Ambarellas Board of Directors, or the Board, currently has seven (7) members. The authorized number of directors may be changed by resolution of the Board. Vacancies on the Board may be filled only by a majority of the remaining directors even if less than a quorum, unless the Board determines that the vacancies shall be filled by the shareholders. A director elected to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until the directors successor is duly elected and qualified.
The Board is divided into three classes, Class I, Class II and Class III, which serve staggered three-year terms:
| Class I directors are Dr. Chenming C. Hu and Dr. Feng-Ming (Fermi) Wang and their current terms will expire at the annual meeting of shareholders to be held in 2019. |
| Class II directors are Leslie Kohn and D. Jeffrey Richardson and their current terms will expire at the annual meeting of shareholders to be held in 2020. |
| Class III directors are Dr. Hsiao-Wuen Hon, Christopher B. Paisley and Andrew W. Verhalen and their current terms will expire at the upcoming Annual Meeting to be held on June 6, 2018. |
Dr. Hsiao-Wuen Hon was appointed to the Board by the remaining directors in August 2017 to fill the vacancy on the Board created when Lip-Bu Tans term expired at the 2017 annual meeting of shareholders. The Board, upon the recommendation of the nominating and corporate governance committee, selected Dr. Hon, Christopher B. Paisley and Andrew W. Verhalen as nominees for election as Class III directors at the upcoming Annual Meeting. The proxies given to the proxy holders will be voted or not voted as directed and, if no direction is given, will be voted FOR each of the three (3) nominees. If any nominee is unable or declines to serve as director at the time of the Annual Meeting, an event not now anticipated, proxies will be voted for any nominee designated by the Board to fill the vacancy. The three (3) nominees for Class III director receiving the highest number of affirmative votes will be elected as Class III directors and will serve until the annual meeting of shareholders to be held in 2021 or until their successors are elected and qualified.
The names of the nominees for election as Class III directors, who have been nominated by the Board, and the names of the continuing directors not up for election at the Annual Meeting, along with certain biographical information about the nominees and continuing directors, including the directors business experience, public company director positions held currently or at any time during the last five years, information regarding involvement in certain legal or administrative proceedings (if applicable), and the experiences, qualifications, attributes or skills that caused the nominating and corporate governance committee to recommend that the director should continue to serve on the Board, are set forth below.
Names of Nominees for Class III Directors |
Age |
Position(s) | ||||
Christopher B. Paisley (1) |
65 | Director | ||||
Hsiao-Wuen Hon, Ph.D (2) |
54 | Director | ||||
Andrew W. Verhalen (2)(3)(4) |
62 | Director |
(1) | Member of Audit Committee |
(2) | Member of Compensation Committee |
(3) | Member of Nominating and Corporate Governance Committee |
(4) | Lead Independent Director |
Christopher B. Paisley has served as a member of our Board since August 2012. Since January 2001, Mr. Paisley has served as the Deans Executive Professor of Accounting at the Leavey School of Business at Santa Clara University. Mr. Paisley also serves on the board of directors of Equinix, Inc., a provider of network
6
colocation, interconnection and managed services, Fitbit, Inc., a provider of fitness wearable devices, and Fortinet, Inc., a provider of unified threat management solutions. Mr. Paisley also served on the board of directors of Volterra Semiconductor Corporation, a provider of power management semiconductors, from April 2002 to October 2013, and YuMe, Inc., a digital media advertising company, from November 2012 to February 2018. Mr. Paisley holds a B.A. degree in business economics from the University of California at Santa Barbara and an M.B.A. from the Anderson School at the University of California at Los Angeles. We believe that Mr. Paisley possesses specific attributes that qualify him to serve as a member of our Board, including expertise in finance, including accounting and financial reporting, as a chief financial officer and in other finance roles and currently as a professor in the field of accounting and finance. Mr. Paisley also has over 15 years of outside board experience, which includes serving as audit committee chairman, at numerous public and private companies.
Hsiao-Wuen Hon, PhD. has been a member of our Board since August 2017. Dr. Hon is currently the Corporate Vice President, Asia-Pacific R&D Group Chairman of Microsoft Corporation (Microsoft), a position he has held since October 2015. Previously, beginning in November 2007, he served as Managing Director of Microsoft Research Asia. Dr. Hon has been employed at Microsoft since 1995 in various capacities, including Deputy Managing Director of Microsoft Research Asia, Chief Architect of the Natural Interaction Service Division, and Principal Researcher. Prior to joining Microsoft, Dr. Hon served as Technology Director of the Apple-ISS Research Center on behalf of Apple Corporation. Dr. Hon received a Bachelor of Science degree in Electrical Engineering from National Taiwan University, a Master of Science degree in Computer Science, Artificial Intelligence from Carnegie Mellon University, and a Ph.D. degree in Computer Science, Artificial Intelligence, Speech Recognition from Carnegie Mellon University. We believe that Dr. Hon possesses specific attributes that qualify him to serve as a member of our Board, including his extensive experience in artificial intelligence and managerial experience in the technology industry as Corporate Vice President, Asia-Pacific R&D Group Chairman of Microsoft.
Andrew W. Verhalen has been a member of our Board since January 2004. Mr. Verhalen has served as a General Partner of Matrix Partners, a venture capital firm, since 1992. He currently serves on the board of directors of two private technology companies in which Matrix Partners has invested and has served in the past on six public technology company boards of directors. Prior to joining Matrix Partners, Mr. Verhalen was an executive at 3Com Corporation from July 1986 through November 1991. He served as Vice President and General Manager of the Network Adapter Division for three years and as a Director or Vice President of Marketing for two years. From July 1981 to July 1986, Mr. Verhalen served in various marketing and strategic planning roles at Intel Corporation. Mr. Verhalen holds a B.S.E.E. degree, a M.Eng. degree and a M.B.A. from Cornell University. We believe that Mr. Verhalen possesses specific attributes that qualify him to serve as a member of our Board, including his experience as a technology-focused investor, which gives him in-depth knowledge of, and exposure to, current technology and industry trends and developments, providing us with insight into our industry and target markets.
Names of Continuing Directors |
Age |
Position(s) | ||||
Chenming C. Hu, Ph.D. (1)(2) |
70 | Director | ||||
Leslie Kohn |
61 | Chief Technology Officer and Director | ||||
D. Jeffrey Richardson (1)(2)(3) |
53 | Director | ||||
Feng-Ming (Fermi) Wang, Ph.D. |
54 | Chairman of the Board of Directors, President and Chief Executive Officer |
(1) | Member of Audit Committee |
(2) | Member of Compensation Committee |
(3) | Member of Nominating and Corporate Governance Committee |
Chenming C. Hu, Ph.D. has been a member of our Board since November 2011. Since 1976 Dr. Hu has been a professor in electrical engineering and computer sciences at the University of California, Berkeley, where he has been the TSMC Distinguished Chair Professor Emeritus and Professor in the Graduate School since 2010.
7
He was the Chief Technology Officer of TSMC from 2001 to 2004. Dr. Hu was the founding chairman of Celestry Design Technologies, which was acquired by Cadence Design Systems in 2002. Dr. Hu also serves on the board of directors of Inphi Corporation, a fabless semiconductor company, and ACM Research, Inc., a semiconductor equipment producer. Dr. Hu previously served as a director of Fortinet, Inc. from 2012 to 2015, and SanDisk Corporation from 2009 to 2016, when it merged with Western Digital Corporation. Dr. Hu is a member of the U.S. National Academy of Engineering and the Chinese Academy of Sciences, and Taiwans Academia Sinica. Dr. Hu received his B.S. degree from National Taiwan University and his M.S. degree and Ph.D. from the University of California, Berkeley, all in Electrical Engineering. We believe that Dr. Hu possesses specific attributes that qualify him to serve as a member of our Board, including his extensive experience in the microelectronics and semiconductor industries as Chief Technology Officer of TSMC and as a current and former board member of a number of technology companies, as well as his experience in academia as a professor of microelectronics, which gives him in-depth knowledge of current technology trends and developments.
Leslie Kohn has served as our Chief Technology Officer and a member of our Board since he co-founded Ambarella in January 2004. Prior to co-founding Ambarella, Mr. Kohn was Chief Technology Officer and co-founder of Afara Websystems from November 2000 to July 2002. After Afaras acquisition by Sun Microsystems in July 2002, Mr. Kohn served as a fellow at Sun Microsystems until August 2003. Mr. Kohn served as Chief Architect of C-Cube Microsystems from February 1995 to October 2000. Prior to joining C-Cube Microsystems, Mr. Kohn served in engineering and management positions with Sun Microsystems, Intel Corporation and National Semiconductor. Mr. Kohn holds a B.S. degree in physics from California Institute of Technology. We believe that Mr. Kohn possesses specific attributes that qualify him to serve as a member of our Board, including his role in developing our technology, his leadership as our co-founder and his years of experience in the digital video industry.
D. Jeffrey Richardson has been a member of our Board since March 2014. Mr. Richardson served as a senior executive of LSI Corporation (LSI), a semiconductor company, from 2005 until LSIs acquisition by Avago Technologies Company in May 2014, including serving as LSIs Executive Vice President and General Manager of the Semiconductor Solutions Group, Executive Vice President of the Networking and Storage Products Group, Executive Vice President and General Manager of the Custom Solutions Group and as Executive Vice President of Worldwide Strategic Planning. Prior to joining LSI, Mr. Richardson served in several capacities at Intel Corporation, including as its Vice President and General Manager of Server Platform Group and Vice President and General Manager of Enterprise Platforms and Services Division. Mr. Richardson currently serves on the board of directors of Lattice Semiconductor Corporation, a semiconductor company, and also served on the board of directors of Volterra Semiconductor Corporation, a provider of power management semiconductors, from April 2011 to October 2013, when Volterra was acquired by Maxim Integrated Products, Inc. Mr. Richardson received a B.S. degree in electrical engineering from the University of Colorado Boulder. We believe that Mr. Richardson possesses specific attributes that qualify him to serve as a member of our Board, including his extensive managerial experience in the semiconductor industry as Chief Operating Officer of LSI and senior management positions with LSI and Intel, and as a board member of Lattice and Volterra.
Feng-Ming (Fermi) Wang, Ph.D. has served as our Chairman of the Board of Directors, President and Chief Executive Officer since he co-founded Ambarella in January 2004. Prior to co-founding Ambarella, Dr. Wang was Chief Executive Officer and co-founder of Afara Websystems, a developer of throughput-oriented microprocessor technology, from November 2000 to July 2002 when Afara was acquired by Sun Microsystems, Inc. Before founding Afara, Dr. Wang served in various positions at C-Cube Microsystems, Inc., a digital video company, from August 1991 to August 2000, and last served as Vice President and General Manager from 1997 to 2000. Dr. Wang holds a B.S. degree in electrical engineering from National Taiwan University and an M.S. degree and Ph.D. in electrical engineering from Columbia University. We believe that Dr. Wang possesses specific attributes that qualify him to serve as a member of our Board, including his service as our Chairman of the Board of Directors, President and Chief Executive Officer, his leadership as a co-founder of Ambarella and his years of experience in the digital video industry.
8
The three (3) nominees for Class III director receiving the highest number of affirmative votes will be elected as Class III directors. Unless otherwise indicated, all proxies received will be voted FOR each of the nominees listed above.
The Board recommends a vote FOR the election of the nominees set forth above as Class III directors of Ambarella.
9
INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
The Board is currently composed of seven members. The Board and its committees met throughout the year on a set schedule and held special meetings from time to time as appropriate. The Board held five meetings during the 2018 fiscal year. Each director attended at least 75% of the total aggregate of the regularly scheduled and special meetings held by the Board and the committees on which such director served during his tenure in fiscal year 2018. Our non-management directors meet in regularly scheduled sessions without the presence of management in executive sessions. The lead independent director of the Board presides over each such executive session. We do not have a policy regarding directors attendance at the Annual Meeting of Shareholders.
Our Corporate Governance Guidelines provide that a majority of our directors will be independent. Based on the review and recommendation by the nominating and corporate governance committee, the Board has determined that Hsaio-Wuen Hon, Chenming Hu, Christopher Paisley, Jeffrey Richardson, and Andrew Verhalen, representing a majority of our directors, are independent directors under the rules of NASDAQ. In making this determination, the Board found that none of these directors or nominees for director had a material or other disqualifying relationship with Ambarella that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Feng-Ming Wang, Ambarellas Chairman of the Board, President and Chief Executive Officer, and Leslie Kohn, Ambarellas Chief Technical Officer, are not independent directors by virtue of their employment with Ambarella.
The Board is currently chaired by Dr. Wang, the President and Chief Executive Officer of Ambarella. We believe that combining the positions of Chief Executive Officer and Chairman helps to ensure that the Board and management act with a common purpose. In our view, separating the positions of Chief Executive Officer and Chairman has the potential to give rise to divided leadership, which could interfere with good decision-making or weaken our ability to develop and implement strategy. Instead, we believe that combining the positions of Chief Executive Officer and Chairman provides a single, clear chain of command to execute our strategic initiatives and business plans. In addition, we believe that a combined Chief Executive Officer and Chairman is better positioned to act as a bridge between management and the Board, facilitating the regular flow of information.
The Board determined as part of our corporate governance principles that one of our independent directors should serve as a lead director at any time when the title of chairman is held by an employee director or there is no current chairman. The lead independent director presides over periodic meetings of our independent directors, has the responsibility of raising issues with management on behalf of the outside directors when appropriate and oversees the function of the Board and committees, among other responsibilities. Mr. Verhalen has served as our lead independent director since June 2017, when he replaced Lip-Bu Tan at the conclusion of Mr. Tans term as a director. The Board has determined that Mr. Verhalen qualifies as an independent director under the rules of NASDAQ.
We believe that the current leadership structure of the Board is appropriate at the present time and allows the Board to fulfill its duties effectively and efficiently based on our current needs.
We have established an audit committee, a compensation committee, and a nominating and corporate governance committee. Each of the committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its responsibilities. The Board has determined that each member
10
of each committee meets the applicable NASDAQ rules and regulations regarding independence and that each member is free of any relationship that would impair his individual exercise of independent judgment with regard to Ambarella. We intend to comply with future requirements as they become applicable to us. Each of the committees operates under a written charter adopted by the Board, each of which can be found on our website at http://investor.ambarella.com. Each committee has the composition and responsibilities described below.
Audit Committee
The audit committee is currently composed of three directors: Mr. Paisley, Dr. Hu and Mr. Richardson. Mr. Paisley serves as the chairman of the committee. The audit committee met five times during fiscal year 2018.
The responsibilities of our audit committee include:
| approving the hiring, discharging and compensation of our independent registered public accounting firm; |
| evaluating the qualifications, independence and performance of our independent registered public accounting firm; |
| reviewing our annual and quarterly financial statements and reports and discussing the statements and reports with our independent registered public accounting firm and management; |
| providing oversight with respect to related party transactions; |
| reviewing, with our independent registered public accounting firm and management, significant issues that may arise regarding accounting principles and financial statement presentation, as well as matters concerning the scope, adequacy and effectiveness of our financial controls; and |
| establishing procedures for the receipt, retention and treatment of complaints received by us regarding financial controls, accounting or auditing matters. |
The Board has determined that Mr. Paisley qualifies as an audit committee financial expert, as defined in applicable SEC rules. The Board made a qualitative assessment of Mr. Paisleys level of knowledge and experience based on a number of factors, including his formal education and experiences as a chief financial officer for public reporting companies, as well as his service on the audit committees of other publicly traded companies. The Board has determined that Mr. Paisleys simultaneous service on multiple audit committees would not impair his ability to effectively serve on our audit committee.
Compensation Committee
The compensation committee is currently composed of four directors: Dr. Hon, Dr. Hu, Mr. Richardson, and Mr. Verhalen. Mr. Richardson currently serves as the chairman of the committee. Dr. Hon joined the committee when he was appointed to the Board in August 2017. The compensation committee formally met six times during fiscal year 2018, and also met informally on several occasions to review matters relevant to the compensation of our executive officers.
The responsibilities of our compensation committee include:
| reviewing and recommending policies relating to compensation and benefits of our executive officers and senior members of management; |
| reviewing and approving or recommending to the Board changes with respect to the compensation levels of our chief executive officer and other executive officers; |
| reviewing and approving corporate goals and objectives relevant to the compensation of our chief executive officer and other executive officers, and evaluating the performance of our chief executive officer and other executive officers in light of the established goals and objectives; |
11
| reviewing and recommending to the Board changes with respect to the compensation of our directors; and |
| administering our stock option plans, stock purchase plans, compensation plans and similar programs, including the adoption, amendment and termination of such plans. |
Each member of the compensation committee is a non-employee director, as defined pursuant to Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended, and an outside director, as defined pursuant to Section 162(m) of the Internal Revenue Code of 1986, as amended, or the Internal Revenue Code.
Nominating and Corporate Governance Committee
The nominating and corporate governance committee is currently composed of two directors: Mr. Richardson and Mr. Verhalen, who currently serves as the chairman of the committee. The nominating and corporate governance committee met one time during fiscal year 2018.
The responsibilities of our nominating and corporate governance committee include:
| reviewing and assessing the performance of the Board, including its committees and individual directors, as well as the size of the Board; |
| identifying, evaluating and recommending candidates for membership on the Board, including nominations by shareholders of candidates for election to the Board; |
| reviewing and evaluating incumbent directors; |
| making recommendations to the Board regarding the membership of the committees of the Board; and |
| reviewing and recommending to the Board changes with respect to corporate governance practices and policies. |
Role of the Board in Risk Oversight
One of the key functions of the Board is informed oversight of our risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through its standing committees that address risks inherent in their respective areas of oversight. In particular, the Board is responsible for monitoring and assessing strategic risk exposure. Our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The audit committee also monitors compliance with legal and regulatory requirements, in addition to oversight of the performance of our external audit function. Our nominating and corporate governance committee monitors the effectiveness of our corporate governance guidelines. Our compensation committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking.
Compensation Committee Interlocks and Insider Participation
During fiscal year 2018, Dr. Hon, Dr. Hu, Mr. Richardson, Mr. Tan and Mr. Verhalen served as members of the compensation committee. Mr. Tan ceased to be a member of the compensation committee when his term on the Board ended in June 2017. None of the members of our compensation committee is or has in the past served as an officer or employee of the Company. None of our executive officers currently serves, or in the past year has served, as a member of the Board or compensation committee of any entity that has one or more executive officers serving on the Board or compensation committee.
12
The Board nominates directors for election at each annual meeting of shareholders and elects new directors to fill vacancies when they arise. The nominating and corporate governance committee has the responsibility to identify, evaluate, recruit and recommend qualified candidates to the Board for nomination or election.
Director Criteria. The nominating and corporate governance committee has a policy regarding consideration of director candidates recommended by shareholders. The nominating and corporate governance committee reviews suggestions for director candidates recommended by shareholders and considers such candidates for recommendation based upon an appropriate balance of knowledge, experience and capability. In addition to considering an appropriate balance of knowledge, experience and capability, the Board has as an objective that its membership be composed of experienced and dedicated individuals with diversity of backgrounds, perspectives and skills. Except as may be required by rules promulgated by Nasdaq or the SEC, there are currently no specific, minimum qualifications that must be met by each candidate for the Board, nor are there any specific qualities or skills that are necessary for one or more of the members of the Board to possess. The nominating and corporate governance committee selects candidates for director based on their character, judgment, diversity of experience, independence, corporate experience, length of service, potential conflicts of interest, and their willingness and ability to devote sufficient time to effectively carry out their duties as a director.
Prior to each annual meeting of shareholders, the nominating and corporate governance committee will identify nominees first by reviewing the current directors whose term expires at the annual meeting of shareholders and who are willing to continue in service. These candidates are evaluated based on the criteria described above, including as demonstrated by the candidates prior service as a director, and the needs of the Board with respect to the particular talents and experience of its directors. In the event that a director does not wish to continue in service, the nominating and corporate governance committee determines not to nominate the director, or a vacancy is created on the Board as a result of a resignation, an increase in the size of the Board or other event, the nominating and corporate governance committee will consider various candidates for Board membership, including those suggested by members of the nominating and corporate governance committee, by other members of the Board, by any executive search firm engaged by the nominating and corporate governance committee and by shareholders.
Shareholder Nominees. In addition, our articles of association contain provisions that address the process by which a shareholder may nominate an individual to stand for election to the Board at our annual meeting of shareholders. In order to nominate a candidate for director, a shareholder must give timely notice in writing to Ambarella, Inc.s Secretary and otherwise comply with the provisions of our articles of association. To be timely, we must have received the shareholders notice not more than 120 days nor less than 90 days prior to the anniversary of the date our proxy statement was provided to shareholders in connection with previous years annual meeting of shareholders. However, if we did not hold an annual meeting of shareholders in the prior year or if the date of the annual meeting of shareholders is more than 30 days before or after the anniversary date of the prior years annual meeting of shareholders, we must receive the shareholders notice not earlier than the close of business on the 120th day prior to the Annual Meeting and not later than the close of business on the later of 90 days prior to the annual meeting of shareholders and the 10th day after the day we provided such public disclosure of the meeting date. Information required by the articles of association to be in the notice include the name and contact information for the candidate and the person making the nomination, the principal occupation or employment of the candidate, the class and number of Ambarella securities held by the candidate, and other information about the nominee that must be disclosed in proxy solicitations under Section 14 of the Securities Exchange Act of 1934 and the related rules and regulations under that Section. We received no director nominees from our shareholders for the upcoming Annual Meeting. Shareholder nominations must be made in accordance with the procedures outlined in, and include the information required by, our articles of association and must be addressed to 3101 Jay Street, Santa Clara, CA 95054, Attn: Secretary. You can obtain a copy of our articles of association by writing to the Secretary at this address.
13
The Board has adopted a formal process by which shareholders may communicate with the Board or any of its directors. Shareholders who wish to communicate with the Board or an individual director may send a written communication addressed as follows: Ambarella Board Communication, 3101 Jay Street, Santa Clara, California 95054. Each communication will be reviewed by the General Counsel of Ambarella who will forward the communication to the Board or to any individual director to whom the communication is addressed unless the communication is of a commercial, frivolous or similarly inappropriate nature, in which case, the General Counsel will discard the communication.
Corporate Governance Principles and Practices
We believe our corporate governance initiatives comply with the Sarbanes-Oxley Act of 2002 and the rules and regulations of the SEC adopted thereunder. In addition, we believe our corporate governance initiatives comply with the rules of The NASDAQ Stock Market.
The Board has adopted a Code of Business Conduct and Ethics that applies to each of our directors, officers and employees. This code addresses various topics, including:
| compliance with laws, rules and regulations, including the Foreign Corrupt Practices Act; |
| conflicts of interest; |
| insider trading; |
| corporate opportunities; |
| competition and fair dealing; |
| equal employment and working conditions; |
| record keeping; |
| confidentiality; |
| giving and accepting gifts; |
| selecting suppliers and fostering partnerships; |
| protection and proper use of Company assets; and |
| payments to government personnel and political contributions. |
The Board also has adopted a Code of Ethics for our Chief Executive Officer and Senior Financial Officers, including our Chief Financial Officer and principal accounting officer, relating to ethical conduct, conflicts of interest and compliance with law. The Code of Conduct and the Code of Ethics for our Chief Executive Officer and Senior Financial Officers is available to shareholders on the investor relations portion of Ambarellas website at www.ambarella.com. Any waiver to the Code of Business Conduct for an executive officer or director or any waiver of the Code of Ethics may only be granted by the Board or a committee of the Board and must be timely disclosed as required by applicable law. We also have implemented whistleblower procedures that establish formal protocols for receiving and handling complaints from employees. Any concerns regarding accounting or auditing matters reported under these procedures will be communicated promptly to our audit committee.
14
Our non-employee directors receive compensation consisting of annual cash retainers for service on our Board and its standing committees, as well as equity grants awarded on an annual recurring basis as they remain a member of the Board. Non-employee directors joining the Board may also receive an equity grant in connection with their appointment to the Board. Our compensation committee periodically reviews compensation for our non-employee directors, including review of competitive practices provided by our compensation consultant. Our compensation committee last modified our non-employee director compensation program for fiscal year 2017 compensation. We believe our non-employee director compensation program provides reasonable compensation to our non-employee directors that is appropriately aligned with our peers and is commensurate with the services and contributions of our non-employee directors.
Cash Retainers. During fiscal year 2018, our non-employee directors received an annual retainer of $35,000, prorated for partial service in any year and paid in cash. Members of our audit committee, compensation committee and nominating and corporate governance committee, other than the chairpersons of those committees, receive an additional annual retainer of $10,000, $6,000 and $4,000, respectively. The chairpersons of our audit committee, compensation committee and nominating and corporate governance committee each receive an additional annual retainer of $15,000, $10,000 and $7,500, respectively and the individual acting as lead independent director, if any, receives an additional $15,000 annually. Cash retainers are paid in arrears at the end of each quarter for service during the previous quarter.
Stock Compensation. For fiscal year 2018, the equity award compensation structure for our non-employee directors generally remained the same as was adopted for fiscal year 2017. Each continuing director received a restricted stock unit award with an initial grant date fair value (determined in accordance with U.S. generally accepted accounting principles) of $200,000 vesting quarterly over 12 months following grant, subject to his continued service through the applicable vesting dates. Accordingly, on September 5, 2017, each of the non-employee directors who were then serving on the Board received a restricted stock unit award covering 4,926 shares.
Equity awards granted to our non-employee directors are subject to the terms and conditions of our 2012 Equity Incentive Plan (the Plan) which provides an annual limit of $500,000 on the total value of equity compensation that may be paid to each continuing non-employee director under the Plan. The Plan also provides an annual limit of $1,000,000 on the total value of equity compensation that may be paid to a new director in connection with being named to the Board. For these purposes, the value of an equity compensation award is determined as grant date fair value, which is determined in accordance with U.S. generally accepted accounting principles.
Stock Ownership Guidelines. The Board believes that all directors should maintain a meaningful personal financial stake in the Company to align their long-term interests with those of our shareholders. We maintain stock ownership guidelines that apply to our executive officers and non-employee directors. This policy requires non-employee directors to attain and maintain a minimum share ownership level equal to at least five times the annual cash retainer, i.e., $175,000 within five years of becoming a director. As of January 31, 2018, all of our non-employee directors satisfy the equity ownership guidelines.
15
Director Compensation for Fiscal Year 2018
The following table sets forth the compensation paid or accrued by us to our non-employee directors during fiscal year 2018. The table excludes Mr. Kohn and Dr. Wang, who did not receive any additional compensation from us in their roles as a director because they are employees of Ambarella.
Name |
Fees Earned or Paid in Cash ($) |
Restricted Stock Awards ($)(1)(2) |
Total ($) | |||||||||
Hsaio-Wuen Hon |
$ | 17,380 | $ | 199,996 | (3) | $ | 217,376 | |||||
Chenming C. Hu |
$ | 51,000 | $ | 199,996 | (4) | $ | 250,996 | |||||
Christopher B. Paisley |
$ | 50,000 | $ | 199,996 | (5) | $ | 249,996 | |||||
D. Jeffrey Richardson |
$ | 57,587 | $ | 199,996 | (6) | $ | 257,583 | |||||
Lip-Bu Tan |
$ | 20,313 | $ | | (7) | $ | 20,313 | |||||
Andrew W. Verhalen |
$ | 58,385 | $ | 199,996 | (8) | $ | 258,381 |
(1) | The dollar amounts in this column represent the aggregate full grant date fair value calculated in accordance with FASB ASC Topic 718 for stock awards granted during the fiscal year ended January 31, 2018. |
(2) | Represents restricted stock unit awards for 4,926 ordinary shares granted on September 5, 2017. |
(3) | Dr. Hon was appointed as a director on August 29, 2017. As of January 31, 2018, Dr. Hon held an outstanding restricted stock unit award covering 3,695 shares. |
(4) | As of January 31, 2018, Dr. Hu held unexercised options to purchase 6,667 shares, and an outstanding restricted stock unit award covering 3,695 shares. |
(5) | As of January 31, 2018, Mr. Paisley held unexercised options to purchase 22,777 shares, and an outstanding restricted stock unit award covering 3,695 shares. |
(6) | As of January 31, 2018, Mr. Richardson held unexercised options to purchase 16,111 shares, and outstanding restricted stock unit awards covering 4,112 shares. |
(7) | Mr. Tans term as a director of the Company ended in June 2017. Mr. Tan was not granted an equity award in fiscal year 2018. |
(8) | As of January 31, 2018, Mr. Verhalen held unexercised options to purchase 11,110 shares, and an outstanding restricted stock unit award covering 3,695 shares. |
16
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The audit committee of the Board has appointed PricewaterhouseCoopers LLP as Ambarellas independent registered public accounting firm, or independent auditors, for the fiscal year ending January 31, 2019, and has further directed that management submit the appointment of independent auditors for ratification by the shareholders at the Annual Meeting. PricewaterhouseCoopers LLP has audited Ambarellas financial statements since fiscal year 2007. Representatives of PricewaterhouseCoopers LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.
Neither Ambarellas Articles of Association nor other governing documents or law require shareholder ratification of the appointment of PricewaterhouseCoopers LLP as Ambarellas independent auditors. However, the audit committee is submitting the appointment of PricewaterhouseCoopers LLP to shareholders for ratification as a matter of good corporate practice. If the shareholders fail to ratify the appointment, the audit committee will reconsider whether or not to retain that firm. Even if the appointment is ratified, the audit committee in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in the best interests of Ambarella and its shareholders.
The affirmative vote of the holders of a majority of the shares present in person or represented by proxy and entitled to vote at the Annual Meeting will be required to ratify the appointment of PricewaterhouseCoopers LLP. Abstentions will be counted toward the tabulation of votes cast on proposals presented to the shareholders and will have the same effect as negative votes.
Principal Accountant Fees and Services
The following table represents aggregate fees billed to Ambarella by PricewaterhouseCoopers LLP for the fiscal years ended January 31, 2017 and 2018, respectively, all of which were approved by the audit committee:
Fiscal Year Ended January 31, |
||||||||
2018 ($) |
2017 ($) |
|||||||
Audit Fees (1) |
1,606,000 | 1,258,100 | ||||||
Audit-Related Fees |
| | ||||||
Tax Fees (2) |
43,250 | 50,000 | ||||||
All Other Fees (3) |
1,800 | 1,800 | ||||||
|
|
|
|
|||||
Total Fees |
1,651,050 | 1,309,900 |
(1) | Audit Fees. The aggregate fees billed for the fiscal years ended January 31, 2018 and 2017 were for professional services rendered for the audits of our consolidated financial statements, statutory audits of our subsidiaries, the review of our interim consolidated financial statements, the audit of the effectiveness of our internal control over financial reporting, services rendered in connection with registration statements on Form S-8, comfort letters and other matters related to the SEC. |
(2) | Tax Fees. The aggregate fees billed for the fiscal years ended January 31, 2018 and January 31, 2017 were for tax advisory and tax compliance services related to tax research and tax planning services in foreign countries in which we do business. |
(3) | All Other Fees consists of fees for access to online accounting and tax research software applications and data. |
17
Pre-Approval Policies and Procedures
The audit committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by our independent auditors, PricewaterhouseCoopers LLP. The policy generally pre-approves specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. Pre-approval may also be given as part of the audit committees approval of the scope of the engagement of the independent auditors or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each service. The pre-approval of services may be delegated to one or more of the audit committees members, but the decision must be reported to the full audit committee at its next scheduled meeting.
The audit committee has determined that the rendering of the services described above by PricewaterhouseCoopers LLP is compatible with maintaining the principal accountants independence.
Ratification of the appointment of PricewaterhouseCoopers LLP requires the affirmative vote of a majority of the shares present and voting at the Annual Meeting in person or by proxy. Unless otherwise indicated, proxies received will be voted FOR ratification of the appointment. In the event ratification is not obtained, the audit committee will review its future appointment of our independent registered public accountants.
The Board recommends a vote FOR the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
18
REPORT OF THE AUDIT COMMITTEE1
The audit committee provides assistance to the Board of Directors in fulfilling its legal and fiduciary obligations in matters involving Ambarellas accounting, auditing, financial reporting, internal control and legal compliance functions by approving the services performed by Ambarellas independent accountants and reviewing their reports regarding Ambarellas accounting practices and systems of internal accounting controls as set forth in a written charter adopted by the Board. Ambarellas management is responsible for preparing Ambarellas financial statements and the independent registered public accountants are responsible for auditing those financial statements. The audit committee is responsible for overseeing the conduct of these activities by Ambarellas management and the independent registered public accountants.
In this context, the audit committee has met and held discussions with management and the independent registered public accountants. Management represented to the audit committee that Ambarellas consolidated financial statements were prepared in accordance with generally accepted accounting principles, and the audit committee has reviewed and discussed the consolidated financial statements with management and the independent registered public accountants. The audit committee has discussed with the independent registered public accountants matters required to be discussed by Statement on Auditing Standards No. 1301, as amended. In addition, the independent registered public accountants provided to the audit committee the written disclosures required by Public Company Accounting Oversight Board Rule 3526 (Communication with Audit Committees Concerning Independence) and the audit committee and the independent registered public accountants have discussed such accountants independence from Ambarella and its management. The audit committee has discussed with Ambarellas internal and independent registered public accountants, with and without management present, their evaluations of Ambarellas internal accounting controls and the overall quality of Ambarellas financial reporting.
In reliance on the reviews and discussions with management and the independent registered public accountants referred to above, the audit committee recommended to the Board, and the Board approved, the inclusion of the audited financial statements in Ambarellas Annual Report on Form 10-K for the fiscal year ended January 31, 2018, for filing with the SEC.
Christopher B. Paisley (Chairman)
Chenming C. Hu
D. Jeffrey Richardson
1 | The material in this report does not constitute soliciting material and shall not be deemed filed or incorporated by reference into any other filing by Ambarella under the Securities Act of 1933 or the Securities Exchange Act of 1934. |
19
ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION
The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the Dodd-Frank Act), allows our shareholders to vote to approve, on an advisory basis, the compensation of our named executive officers. At our annual meeting of shareholders held in 2015, the Companys shareholders approved, on an advisory basis, soliciting a shareholder advisory vote on the compensation of our named executive officers on an annual basis and the Company holds such advisory votes on the compensation of our named executive officers annually. Accordingly, this year we again are asking our shareholders to provide an advisory vote to approve the compensation of our named executive officers, including the Compensation Discussion and Analysis section, along with the accompanying compensation tables and narrative disclosures as described in this Proxy Statement. This proposal, commonly known as a say-on-pay proposal, gives our shareholders the opportunity to express their views on the compensation of our named executive officers.
The say-on-pay vote is advisory, and as such is not binding on the Company, but it does provide the compensation committee with valuable information about shareholder opinion of our executive compensation policies and programs for consideration when determining executive compensation in the future. After the say on pay vote at this years annual meeting of stockholders, the next say-on-pay vote will be scheduled to occur at the Companys annual meeting of stockholders in 2019.
Please see the Compensation Discussion and Analysis section of this Proxy Statement beginning on page 22, the accompanying compensation tables and the narrative disclosures for greater detail about our executive compensation programs, including information about the fiscal year 2018 compensation of our named executive officers. We believe that our executive compensation programs have been effective in achieving long-term alignment of management and shareholder interests, consistent with the Companys philosophy on pay and performance.
We ask that you vote FOR the follow resolution:
RESOVLED: That the shareholders of Ambarella, Inc. hereby approve, on an advisory basis, the compensation of the named executive officers, including the Compensation Discussion and Analysis, compensation tables and the narrative discussion, as disclosed in the Proxy Statement furnished for the 2018 Annual Meeting of Shareholders pursuant to the compensation disclosure rules and regulations of the U.S. Securities and Exchange Commission.
Approval, on an advisory basis, of named executive officer compensation requires the affirmative vote of the holders of a majority of the shares present and voting at the Annual Meeting in person or by proxy. Unless otherwise indicated, proxies received will be voted FOR approval, on an advisory basis, of named executive officer compensation.
The Board unanimously recommends a vote FOR the approval, on an advisory basis, of the compensation of our named executive officers as disclosed in this Proxy Statement.
20
The following table sets forth certain information about our executive officers and their respective ages as of March 31, 2018. There are no family relationships among any of our directors or executive officers.
Name |
Age |
Position(s) | ||||
Feng-Ming (Fermi) Wang, Ph.D. |
54 | Chairman of the Board of Directors, President and Chief Executive Officer | ||||
Leslie Kohn |
61 | Chief Technology Officer and Director | ||||
George Laplante |
66 | Chief Financial Officer | ||||
Yun-Lung (Michael) Chen |
53 | Vice President, Business Development | ||||
Christopher Day |
54 | Vice President, Marketing and Business Development |
Feng-Ming (Fermi) Wang, Ph.D. and Leslie Kohn. For brief biographies of Dr. Wang and Mr. Kohn, please see Proposal 1 Election of Class III Directors above.
George W. Laplante has served as our Chief Financial Officer since March 2011. As announced by the Company on April 18, 2018, Mr. Laplante intends to retire in 2018, and the Company has initiated a search for his replacement. Mr. Laplante intends to remain in his current role until a successor is named and an orderly transition is completed. From May 2009 to March 2011, Mr. Laplante served as a management consultant and interim chief financial officer to several private technology companies. From March 2007 to May 2009, Mr. Laplante served as the Chief Financial Officer and Secretary of Santur Corporation, a manufacturer of laser technology for the communications industry. From September 2000 to December 2006, Mr. Laplante served as the Chief Financial Officer and Secretary of 2Wire, Inc., a provider of broadband services platforms. Prior to joining 2Wire, Mr. Laplante held finance and management positions at Action Computer Supplies Holdings Plc., ACS Distribution, Inc., Arneson Marine, Inc., Molecular Computer, and Televideo Systems, Inc. Mr. Laplante began his career as a CPA with Arthur Andersen & Company. Mr. Laplante holds a B.A. degree in Economics from Southern Connecticut State College and a Masters in Accountancy from Bowling Green State University.
Yun-Lung (Michael) Chen has served as our Vice President, Business Development since June 2011, and was Sr. Director of Sales from January 2005 to June 2011. Prior to joining Ambarella, Mr. Chen was Director of Sales for Marvell Technology, a semiconductor company, from December 2002 to October 2003. From October 1997 to October 2002, Mr. Chen served as Director of Sales for Wintech Microelectronics, a distributor of electronics. Mr. Chen holds a B.S. degree in industrial engineering from Tung Hai University in Taiwan.
Christopher Day has served as our Vice President, Marketing and Business Development since March 2010. Prior to joining Ambarella, Mr. Day was President and Chief Executive Officer of Mobilygen, Inc., a video compression company from March 2007 to October 2008, prior to acquisition by Maxim Integrated Products, Inc., and then served as Executive Director of Business Management of Maxim until March 2010. From February 2002 to February 2007, Mr. Day served as General Manager of Media Processing at NXP Semiconductors N.V., formerly Philips Semiconductor. From February 1998 to May 2001, Mr. Day served as Senior Director of Marketing for C-Cube Microsystems. Prior to joining C-Cube Microsystems, Mr. Day held sales and marketing positions at AuraVision, Inc., Motorola, Inc., and Hitachi, Ltd. Mr. Day holds a B.S. degree in computer and microprocessor systems from Essex University in the United Kingdom, and an M.B.A. from Santa Clara University.
21
Compensation Discussion and Analysis
This Compensation Discussion and Analysis discusses the compensation programs and policies for our named executive officers (NEOs) for fiscal year 2018, ended January 31, 2018, who were:
Name |
Position(s) | |
Feng-Ming (Fermi) Wang, Ph.D. |
Chairman of the Board of Directors, President and Chief Executive Officer | |
Leslie Kohn |
Chief Technology Officer | |
George Laplante |
Chief Financial Officer | |
Yun-Lung (Michael) Chen |
Vice President, Business Development | |
Christopher Day |
Vice President, Marketing and Business Development |
The information contained in this Compensation Discussion and Analysis should be read in connection with the compensation tables below, which provide a detailed view of the compensation paid to our NEOs in fiscal year 2018.
Executive Summary
Pay for Performance. The cornerstone of our executive compensation program is pay for performance. Accordingly, while we pay competitive base salaries and other benefits, a significant portion of each of our NEOs compensation opportunity is based on variable pay in the form of performance-based cash bonuses and equity awards. For fiscal year 2018, we implemented a new framework for our equity awards granted to our NEOs utilizing performance-based awards designed to focus our executive officers on key strategic objectives as well sustained long-term growth. The composition of the total annual compensation of our chief executive officer (CEO) for fiscal year 2018, as reported in the Summary Compensation Table further below, was as follows:
Fiscal Year 2018 Business Highlights. We are a leading developer of semiconductor processing solutions for video that enable high-definition, or HD, video capture, analysis, sharing and display. Our system-on-a-chip, or SoC, designs integrate HD video processing, image processing, computer vision, audio processing and system functions onto a single chip, delivering exceptional video and image quality at high compression rates, differentiated functionality and low power consumption. Our platform enables the creation of high-quality video content in wearable cameras, automotive recording cameras, professional and consumer IP security cameras, cameras incorporated into drones, and virtual reality cameras, also referred to as 360° cameras. While our revenue in the last three years has been driven primarily by sales into specialized video and image capture devices such as IP security cameras, wearable sports cameras, automotive aftermarket cameras, and drones, we
FY2018 CEO Compensation Mix Base Salary Performance-Based Cash Bonus Time-Based RSUs Performance-Based PRSUs
22
believe that our long-term success will be dependent upon moving beyond our traditional markets. To this end, we have expended substantial resources in the development of computer vision technology that we believe will provide us with significant opportunities in both our current markets as well as new markets, such as the OEM automobile market and robotics applications. In fiscal year 2018, we made substantial progress in developing our computer vision technology, and introducing new products incorporating this technology, which we believe will provide us with competitive advantages and allow us to address new, larger markets.
In fiscal year 2018, we achieved several significant business results, including:
| Annual revenues of $295.4 million and cash flows from operating activities of $85.4 million; |
| Achieving strong revenue growth in our key markets of professional and consumer IP security cameras and automotive OEM; |
| Introducing our first computer vision solution, the CV1 processor, which is the first in a family of UHD computer vision processors based on our new CVflow computer vision architecture; |
| Introducing our CV22 SoC, our first 10nm chip and the second chip in our CVflow family, providing computer vision processing required for the next generation of intelligent home monitoring, automotive, drone, and wearable cameras; and |
| Introducing our S5L SoC, designed for both professional and battery-powered IP cameras, providing 4K HDR processing, multi-streaming, and a quad-core ARM Cortex A53 CPU for advanced analytics including object and person detection. |
As a result of our computer vision development efforts, we were able to begin demonstrating our new computer vision technology to both existing and potential customers, including automotive OEMs and Tier I suppliers to the automotive market. In addition, we recently began our own autonomous driving testing in California.
Fiscal Year 2018 Executive Compensation Highlights. Our executive compensation program is designed to motivate, engage, and retain a talented executive leadership team and to appropriately reward them for their contributions to our business. In fiscal year 2017, the compensation committee of our Board (the compensation committee) undertook a holistic review of our executive compensation programs, resulting in several changes implemented in fiscal year 2018. The largest portion of our executives compensation continues to be variable and tied directly to the achievement of annual and longer-term strategic and financial goals. Key compensation highlights from fiscal year 2018 include:
| No increase in salary: We did not provide NEOs with salary increases in fiscal year 2018 as we continue to emphasize the importance of variable pay tied to the achievement of strategic and financial goals. |
| Annual bonus pool paid out below target: Overall executive bonus payout was approximately 48% of the total target. Revenue performance, which comprised 50% of the weighting of performance goals, did not meet the minimum threshold and no bonus was paid out to NEOs for this component. Operating income performance, which also comprised 50% of the weighting, was slightly below target and paid out at 97% of target for this component. |
| Discretionary reduction in CEO bonus allocation: The overall executive bonus pool paid out at 48% of target as a result of revenue and profitability performance for the year. The compensation committee decreased the CEOs share of the bonus pool such that his payout was only 27% of target. |
| Enhanced focus on long-term performance in fiscal year 2018 equity design: A substantial portion of the total annual compensation of our NEOs in fiscal year 2018 remained equity awards. Beginning in fiscal 2018, we granted equity awards using a new framework which places greater emphasis on long-term performance. |
| Performance Framework to Size Fiscal Year 2018 Award: The magnitude of equity granted each year, including both restricted stock units with time-based vesting and performance-based |
23
restricted stock units, can be adjusted up or down from the target grant size based on the compensation committees structured assessment of annual financial performance, and the companys historical performance relative to the compensation peers on revenue growth, operating margin, and relative total shareholder return (TSR) over one- and three-year periods. |
| Performance-Based Restricted Stock Units: We added performance-based restricted stock unit awards to our executive compensation program in fiscal year 2018. 50% of equity awards for the CEO (and 30% for the other NEOs) was granted as performance-based restricted stock units (also referred to as PRSUs). Vesting of the PRSUs is subject to the achievement of three key strategic priorities for fiscal year 2018, and subject to adjustment based on a three-year TSR metric. |
| PRSU Performance Outcome: The Company achieved two of the three strategic priorities set for the fiscal year 2018 PRSU awards. As a result, the fiscal year 2018 PRSU award is currently tracking at a payout of 100% of target. The final award payout will be subject to possible increases or decreases by up to 25% of target based on our relative TSR performance over the three-year period ending in 2020. |
Change in CEO Equity Target for Fiscal Year 2019. The compensation committee reduced our CEOs target equity pay, the largest component of our compensation structure, by 15% beginning in fiscal year 2019 after a review of market pay levels.
Corporate Governance Best Practices
What we do: |
What we dont do: | |
Link pay and performance by establishing corporate performance objectives under our fiscal year 2018 plan and granting a substantial portion of pay in the form of equity awards, including performance-based awards
Have stock ownership guidelines for our NEOs
Have a clawback policy for performance-based compensation paid to our NEOs
Have double-trigger change in control provisions in our NEO severance agreements
Have a retained an independent compensation consultant to assist our compensation committee
Maintain an anti-hedging policy that applies to all of our executive officers
Maintain an anti-pledging policy that applies to all of our executive officers
Conduct annual say-on-pay advisory votes |
✗ Have employment agreements with NEOs
✗ Pay excessive perquisites to NEOs |
Framework for Determining Executive Compensation
Overview
Our executive compensation program has focused primarily on attracting executive talent to manage and operate our business, retaining individuals who are key to our growth and success, and rewarding individuals
24
who help us achieve our business objectives. Our industry is characterized by high demand and intense competition for talent, including engineering personnel as well as management talent. The pool of qualified candidates is often limited, particularly in Silicon Valley, and we often compete for talent with companies much larger than us and our peer group of companies (described below). To support these objectives, we provide a competitive total compensation package to our executive officers that we believe achieves the following:
| motivates and rewards highly-talented individuals whose skills, knowledge and performance are critical to our success; |
| links overall compensation to achieving corporate objectives set at the beginning of each year and to individual performance during the year; |
| creates long-term incentives for management to increase shareholder value by having a significant portion of compensation tied to our long-term success; and |
| provides total compensation that is fair, reasonable and competitive. |
Since our initial public offering in 2012, we have continued to make incremental changes to our executive compensation program to adopt practices that are appropriate for the Company given our business, industry, size, growth, and other factors. We have engaged an independent compensation consultant since our initial public offering, including for fiscal year 2018, which assists our compensation committee in determining executive compensation. Over the last few years, we have considered and used different types of equity awards to grant our NEOs, as we strive to establish the appropriate mix that continues to provide for emphasis on pay for performance, compensation that is competitive with the market, and appropriate incentive to drive our business success and retain our key talent. Consistent with our continued focus on performance, our compensation committee and the board of directors have not made adjustments to our NEOs base salaries since our initial public offering, except in the case of the appointment of a new executive officer.
The Role of the Compensation Committee and Board of Directors
The compensation committee is responsible for the executive compensation program for our executive officers. The compensation committee formally met six times during fiscal year 2018, and also met informally on several occasions, to review and discuss matters related to compensation of our employees and executive officers. Some of these meetings were held with members of management in attendance and some were held in closed session. Many of the meetings also included members of our compensation consultant (as described below). Typically, the compensation committee reports to the Board on its discussions and recommends to the Board the decisions to be made and other actions to be taken with regard to our executive officers compensation. Our compensation committees recommendations regarding executive compensation are based on the compensation committees assessment of the performance of the Company and each individual executive officer, as well as other factors, such as prevailing industry trends and the competitive market for executive talent. The Board (or the independent members regarding CEO compensation) typically makes the final decisions regarding executive compensation.
The Role of Management
Our CEO and Chief Financial Officer (CFO) typically make recommendations to our compensation committee, attend certain compensation committee meetings and are involved in the process for setting our executive officers compensation, provided that neither our CEO nor our CFO makes recommendations as to his own compensation. Our compensation committee considers their recommendations but is not required to follow any recommendations and may adjust compensation up or down as it determines in its discretion. Our compensation committee reviews the recommendations and other data and makes recommendations to the Board as to each executive officers total compensation, as well as each individual compensation component.
25
The Role of the Compensation Consultant
The compensation committee has authority to appoint and retain a compensation consultant. The reasonable fees for services rendered by the compensation consultant are paid by the Company. For fiscal year 2018, our compensation committee engaged Semler Brossy Consulting Group (Semler Brossy) to provide compensation consulting services and Semler Brossy served at the discretion of compensation committee. Semler Brossy provided services to the compensation committee for fiscal year 2018, including presenting market data, including our compensation peer group companies (as described further below) to the compensation committee; analyzing our NEOs salary and short-term incentive and equity incentive compensation in relation to market data; assisting the compensation committee with updating our equity incentive program to place greater emphasis on sustained long-term growth and to create incentive to achieve key strategic goals; assisting the compensation committee with a risk assessment; and attending compensation committee meetings as requested by the compensation committee. Semler Brossy provides no services to Ambarella other than those it provides to the compensation committee. The compensation committee assesses Semler Brossys independence annually under SEC and NASDAQ standards and has concluded that Semler Brossy was independent.
Peer Companies
In setting executive compensation for fiscal year 2018, our compensation committee considered the compensation data gathered by Semler Brossy for the Companys peer group of companies, although it did not benchmark or otherwise target our compensation to any specific percentile or range with respect to our compensation peers. The Companys peer group used for determining executive compensation for fiscal year 2018 consisted of the following 14 companies:
3D Systems | Monolithic Power Systems | |
Cavium | Power Integrations | |
Cognex | Rambus | |
Integrated Device Technology | Semtech | |
Intersil | Silicon Laboratories | |
InvenSense | Xperi Corporation (formerly Tessera Technologies) | |
M/A-Com Technology Solutions Holdings | Universal Display |
Generally, the compensation peer group is determined based on technology companies in the semiconductor and semiconductor equipment and electronic components industries that are of comparable size to the Company and have achieved profitability. We believe that many of the companies with which we compete for talent are significantly larger than these peer companies and offer higher compensation packages. The compensation committee regularly reviews the list of companies in our compensation peer group to ensure that they represent comparable peers.
Annual Stockholder Say on Pay Vote. At our June 2017 annual meeting of shareholders, which was held during fiscal year 2018, we conducted our most recent non-binding, advisory vote on the compensation of our NEOs, commonly referred to as a say-on-pay vote. Our shareholders showed strong support, with over 95% of the votes cast in favor of our NEO compensation program. By the time the results of the most recent say-on-pay vote became available, our compensation committee already had made much of the design determinations regarding our fiscal year 2018 NEO compensation program. Accordingly, in making such decisions, the compensation committee was guided in part by the prior say-on-pay vote results, which also showed strong support by our shareholders. The compensation committee was mindful of this support, as well as feedback received from proxy advisory firms and our continuing commitment to a pay for performance strategy. After considering the advisory say on pay vote that occurred in fiscal year 2017, the additional feedback we received, and our holistic review in fiscal year 2017 of our compensation programs, the compensation committee determined to retain our general approach to executive compensation, but with an increased emphasis on compensation that focuses on sustained, long-term growth, achievement of our key strategic goals and the creation of value for our stockholders.
26
Elements of Executive Compensation
The compensation of our NEOs consists of the following principal components:
| base salary; |
| performance-based cash bonuses; |
| equity incentive awards; and |
| severance and change of control benefits. |
We strive to achieve an appropriate mix between cash compensation and equity incentive awards to meet our objectives. We do not apply any formal or informal policies or guidelines for allocating compensation between current and long-term compensation, or between cash and equity compensation. We believe the most important indicator of whether our compensation objectives are being met is our ability to motivate our executive officers to deliver superior performance and retain them to continue their careers with us on a cost-effective basis. Our Board, led by our compensation committee, generally conducts an annual review of our executive compensation, as well as the mix of components used to compensate our executive officers. In reviewing and setting the executive compensation for fiscal year 2018, our Board relied on its collective judgment, recommendations from Dr. Wang (for executives other than Dr. Wang), the relative pay among the management team members and its assessment of each executive officers role and overall contribution to the business in determining the size and mix of compensation for each executive, and Semler Brossys analysis of executive pay practices of the Companys compensation peers. Given our strong commitment to pay for performance, the large majority of each NEOs target direct compensation (salary, target cash bonus opportunity, and target equity awards) was variable and subject to the achievement of key performance objectives that are important for the growth and success of the Company.
Base Salary
Our base salaries are intended to provide financial stability, predictability and security of compensation for our executive officers for fulfilling their core job responsibilities. The base salaries of our NEOs are based primarily on the scope of their responsibilities, experience, performance and contributions, and our compensation committees understanding of compensation paid to similarly situated executives. None of our NEOs has an employment agreement that provides for automatic or scheduled increases in base salary.
Base salaries for our NEOs have remained unchanged since our initial public offering in October 2012 (or the NEOs later appointment as an officer, as applicable). The following table sets forth the annual base salary for each of our NEOs for fiscal year 2018:
Name |
Year 2018 Base Salary |
Change from Fiscal Year 2017 |
||||||
Fermi Wang |
$ | 340,000 | 0 | % | ||||
Leslie Kohn |
$ | 320,000 | 0 | % | ||||
George Laplante |
$ | 320,000 | 0 | % | ||||
Michael Chen (1) |
$ | 232,350 | 0 | % | ||||
Christopher Day |
$ | 245,000 | 0 | % |
(1) | Mr. Chen is paid in Taiwan. His salary for fiscal year 2018 remained consistent in Taiwan dollars with his salary for fiscal year 2017. |
Performance-Based Cash Bonuses
Our NEOs are eligible to receive cash bonuses under our annual bonus plan established at the beginning of the fiscal year. Annual cash bonuses are intended to motivate our executives to achieve, and reward our executives for achieving, important corporate financial and operational goals, as well as individual performance.
Target Pool Set Performance Goals Set Performance Achieved and Certified (Poo1 funding between 70% -135% of Target) Pool AIIocated to Executives based on Certified Performance
27
An annual bonus pool for employees and executives is established by the Board at the time the Companys annual operating budget is approved by the Board. In establishing the Fiscal Year 2018 Annual Bonus Plan, the Board deemed it appropriate to link compensation to our actual financial performance. Consistent with the prior fiscal years, the two equally weighted performance goals were annual revenue and annual operating profit, before bonus accruals. Once achievement of these performance goals has been certified by the Board, the pool size is adjusted to between a threshold of 70% and a maximum of 135%. The pool is then distributed to individual executives as determined by the Board based on factors such as historical allocation, the executives individual contribution to the Companys financial results and market competitiveness for similar positions.
Corporate Performance Goals. Consistent with recent years, performance goals under the Fiscal Year 2018 Annual Bonus Plan included annual revenue (based on GAAP) and annual operating profit, before bonus accruals (a non-GAAP metric), which were equally weighted. These performance objectives were chosen because the compensation committee and Board believe that these are important financial metrics that reflect our performance as a growing company. While revenue growth remained an important focus for the Companys overall growth and business success, the operating profit goal also was important to ensure that such top-line growth was balanced with efforts in achieving profitable growth and the management of expenses. The operating profit goal is a non-GAAP measure and refers to our GAAP operating income less the impact of stock-based compensation and the associated tax impact. For fiscal year 2018, we set a revenue target of $313.5 million, representing 1% growth over fiscal year 2017, but which required substantial revenue growth in our key IP security camera and automotive OEM markets. For fiscal year 2018, we set an operating income target of $89.6 million. In setting these targets, the compensation committee and Board considered our then-current operating plan for fiscal year 2018, then-current forecasts and projections, as well as prevailing industry conditions, and intended that the difficulty of attaining the goals would be relatively consistent with prior years and would require strong operational performance. The primary challenges for fiscal year 2018 included growing revenue in markets other than sports cameras and drones, such as the IP security camera and automotive markets, and continuing to invest substantially in the Companys computer vision technology while maintaining profitability.
At target achievement of the performance goals, 100% of the approved bonus pool would become funded and available for payment to executives. Maximum achievement of the performance goals at $341 million in revenue and $104 million in operating profit before bonus would result in 135% of the bonus pool becoming funded and payable. Threshold performance at $301 million in revenue and $73 million in operating profit before bonus would result in 70% of approved bonus pool being funded. Failure to achieve neither of the threshold performance goals would result in none of the bonus pool becoming payable. Payouts between performance targets is based on a linear interpolation. Under our Fiscal Year 2018 Annual Bonus Plan, our compensation committee and board of directors had the discretion to reduce, eliminate or increase the size of the bonus pool and the individual bonuses. No upward discretionary adjustments were made to the bonus pool for fiscal year 2018.
28
Bonus Opportunity. Actual allocation of the pool to each executive officer for fiscal year 2018, including our NEOs, was made by the Board (with the recommendation of the compensation committee) at the conclusion of the fiscal year based on historical allocation, the executives individual contribution to the Companys financial and operational results and with a focus on executive retention in light of prevailing market conditions in our industry, and taking into consideration Dr. Wangs recommendations for NEOs other than himself. The compensation committee believes strongly in the alignment of CEO pay with overall company performance. As a result, Dr. Wangs allocation of the bonus pool in 2018 was decreased substantially from prior years.
Name |
Fiscal Year 2017 Share of Bonus Pool |
Fiscal Year 2018 Share of Bonus Pool |
||||||
Fermi Wang |
32.1 | % | 18.0 | % | ||||
Leslie Kohn |
15.8 | % | 18.0 | % | ||||
George Laplante |
14.0 | % | 17.4 | % | ||||
Michael Chen |
7.5 | % | 9.0 | % | ||||
Christopher Day |
7.2 | % | 9.0 | % | ||||
Other Executives (Not NEOs) |
23.4 | % | 28.6 | % |
Fiscal Year 2018 Performance. For fiscal year 2018, we fell short of the target revenue goal and minimum threshold amount, resulting in no funding of the executive bonus pool for the revenue metric. For fiscal year 2018, we fell slightly short of the target level for the operating profit goal, resulting in a partial funding of the executive bonus pool for the operating profit metric. As a result, bonuses were paid out substantially below target for each of our NEOs.
Metric |
Weight | Target Performance Goal |
Actual Results |
Payout Factor (% of Target) |
||||||||||||
Revenue |
50 | % | $ | 313.5 | $ | 295.4 | 0 | % | ||||||||
Operating Income |
50 | % | $ | 89.6 | $ | 87.7 | 97 | % | ||||||||
Total |
100 | % | 48 | % | ||||||||||||
Actual Fiscal Year 2018 Bonus Payments. As a result of the 48% target pool funding, and the individual pool allocation outlined above, our NEOs received the following bonuses for fiscal year 2018:
Name |
Fiscal Year 2018 Bonus |
Fiscal Year 2017 Bonus |
Change from FY2017 to FY2018 |
|||||||||
Fermi Wang |
$ | 160,000 | $ | 604,495 | -74 | % | ||||||
Leslie Kohn |
$ | 160,000 | $ | 296,752 | -46 | % | ||||||
George Laplante |
$ | 155,000 | $ | 263,780 | -41 | % | ||||||
Michael Chen |
$ | 80,000 | $ | 140,683 | -43 | % | ||||||
Christopher Day |
$ | 80,000 | $ | 136,286 | -41 | % |
Incentive Awards
Equity-based compensation has been our primary long-term incentive compensation component. Our equity-based compensation is intended to offer both retention incentives and long-term performance, through equity awards with a mix of time-based vesting and performance-based vesting. We continue to believe that shared financial success in long-term incentives motivates our executive officers to grow revenue and earnings, enhance shareholder value and more closely align the interests of our shareholders and executives.
Change in Long-Term Incentive Design: As part of our holistic review of compensation programs in fiscal year 2017 we updated our annual equity grant structure, which was used for fiscal year 2018. Accordingly,
29
PRSUs were introduced to our equity program in fiscal year 2018. The modifications were a result of feedback received from proxy advisory firms, our independent compensation consultant, and our review of current market practices. The change in design was intended to further focus executive officers on sustained long-term growth in the coming years and to create a significant incentive to achieve key strategic priorities. Under the design, 50% of equity awards for the CEO (and 30% for other NEOs) was granted as performance-based restricted stock units (PRSUs) and the remainder was granted as restricted stock units subject to time-based vesting over multiple years. This mix balanced our emphasis on tying our long-term financial performance and shareholder value creation to the executive officers financial gain, with our need to effectively retain our key talent. The initial equity grants to our NEOs under this modified structure were made in March 2017 and are reflected in fiscal year 2018 compensation. For fiscal year 2018, the Board, upon recommendation of the compensation committee, established a target equity award pool, which included both time-based and performance-based restricted stock units, for our NEOs and other executives. The compensation committee retained the discretion to adjust this pool up or down from target based on the compensation committees assessment of annual financial performance, and the Companys historical relative performance to the compensation peers on revenue growth, operating margin, and relative TSR. After the adjustment to the size of the pool was made, equity award grants were allocated to individual executives based upon a number of factors, including individual performance, retention needs, historical allocations and competitive market data, as follows:
Name |
Time-based RSUs (#) |
PRSUs (at Target) (#) |
||||||
Fermi Wang |
39,437 | 39,437 | ||||||
Leslie Kohn |
26,131 | 11,199 | ||||||
George Laplante |
21,045 | 9,019 | ||||||
Michael Chen |
9,295 | 3,984 | ||||||
Christopher Day |
8,769 | 3,785 |
Typically, stock awards are granted effective two trading days after our quarterly earnings call that discusses our most recently ended fiscal quarter financial results. The compensation committee and board of directors believe that the granting of awards after the trading window opens several days following the earnings call helps to reduce the risk that awards coincide with the possession of material, non-public information.
30
* | Restricted stock units granted in fiscal year 2018 vest quarterly over two years |
Performance-Based Restricted Stock Unit Design Detail: Payout is based on achievement of three fiscal year 2018 key strategic priorities as well as our three-year TSR relative to the companies in the Philadelphia Semiconductor Index. Performance on these three strategic priorities is objectively measured, and is certified by the compensation committee. For fiscal year 2018, the three strategic priorities related to engaging customer evaluation of our computer vision technology; completing development of our second generation computer vision chip; and achieving an automotive end-customer design win goal. If one of the three strategic objectives was achieved, 50% of the target number of PRSUs would pay out; if two of the three strategic objectives were achieved, then 100% of the target number of PRSUs would pay out; and if all three strategic objectives were achieved, then 150% of the target number of PRSUs would pay out. Performance is further modified by our three-year TSR relative to the Philadelphia Semiconductor index measured through January 31, 2020. Relative TSR performance in the bottom third of companies results in a payout decrease of 25% of target, and performance in the top third of companies results in a payout increase of 25% of target. All earned PRSUs will cliff vest, subject to continued service of the executive, following the end of the three-year TSR performance period. In addition, in order to help ensure that in the event of a potential change of control of the Company and/or an NEOs termination of employment with us, each NEOs focus remains closely aligned with those of our stockholders, the performance goals and time-based vesting schedules are subject to certain adjustments and accelerations in connection with a change in control or termination of the NEOs employment in certain circumstances, as described in section of this proxy entitled Performance-based Restricted Stock Units, below.
Achievement of the strategic performance objectives was significant in enabling the Company to establish itself as a provider of computer vision solutions for our existing and new markets, including the automotive OEM market, which was a key strategic objective for fiscal year 2018. At the time the PRSUs were awarded, the Company believed the three performance objectives were achievable with significant effort and focus on the part of our NEOs. Ultimately, we achieved two of the three strategic objectives, and 100% of the target PRSUs are currently projected to vest in March 2020. The final vesting amount my increase or decrease by up to 25% of the target number of PRSUs based on relative TSR performance for the period of fiscal year 2018 to fiscal year 2020.
Target Equity Mix Performance Share Metrics (0.5x-1.5x leverage based on number of metrics achieved) 3yr Performance Modifier (modifies payout by +/- 0.25x target) 50% for CEO (30%for Other Execs) Performance Shares (Cliff vests three after grant) Strategic Goal 1 50% for CEO (70% for Other Execs) Restricted Shares (Vest quarterly over three years on ongoing basis*) Strategic Goal 2 Strategic Goal 3 Target Equity Mix Achievement of 1 of 3 results in 0.5x of target payout Achievement of 2 of 3 results in 0.5x of target payout Achievement of 3 of 3 results in 0.5x of target payout 3yr relative total shareholder return (rTSR) Performance measured relative to the companies Philadelphia Semiconductor Index Performance in bottom third of companies results in 25% decrease in payout Performance in top third of companies results in 25% increase in payout Performance in middle third of companies results in no change in payout
31
Time-Based Restricted Stock Unit Design Detail: One-half of equity awards for our CEO (and 70% for the other NEOs) was granted as restricted stock units subject to time-based vesting. The compensation committee and Board determined that for fiscal year 2019 and beyond, these annual restricted stock units granted to our NEOs would be expected to vest in equal quarterly installments over the three years following grant, subject to continued service of the executive. For fiscal year 2018 only, the compensation committee and Board decided that restricted stock units would vest quarterly over the two years following grant for the CEO (and two and one-half years for the other NEOs). The shorter vesting period for fiscal year 2018 restricted stock units is intended to bridge the cash flow gap individual executives will experience as a result of moving to PRSUs with a three-year cliff vesting schedule from prior designs with a ratable vesting schedule.
Severance and Change of Control Benefits
Employment of our executive officers is at will. Prior to our initial public offering, we entered into severance and change of control agreements with Dr. Wang and Messrs. Laplante, Kohn and Day, pursuant to which they are entitled to receive compensation and other benefits in connection with certain terminations of employment and terminations of employment in connection with a change of control event.
Our goal in providing certain severance and change of control benefits is to offer sufficient cash continuity protection such that the executive will focus his full time and attention on the requirements of our business rather than the potential implications for his respective position. We prefer to have certainty and internal parity regarding the potential severance amounts payable to our NEOs under certain circumstances, rather than negotiating severance at the time that an NEOs employment terminates. We have also determined that accelerated vesting provisions are appropriate because they will encourage our NEOs to stay focused in such circumstances, rather than the potential implications for them.
These agreements are described in more detail below under Employment, Severance and Change of Control Arrangements.
Broad Based Employee Benefits
We believe that establishing competitive benefit packages for our employees is an important factor in attracting and retaining highly qualified personnel. Each NEO is eligible to participate in all of our employee benefit plans generally applicable to employees on a broad basis in the country in which the executive is located. Our U.S.-based NEOs are eligible to participate in our U.S.-based employee benefits plans, such as medical, dental, disability, vision, group life and accidental death and dismemberment insurance, our patent incentive program and our 401(k) plan, in each case on the same basis as other U.S.-based salaried employees. Mr. Chen is based in Taiwan and as a result, he participates in the generally available employee benefit plans maintained for our Taiwan employees.
We do not offer excessive perquisites to any of our NEOs as that would be inconsistent with our egalitarian corporate culture.
Anti-hedging and Anti-pledging
Under our insider trading policy, our NEOs are prohibited from any hedging or similar transactions designed to decrease the risks associated with holding our securities. In addition, our NEOs may not pledge our securities as collateral for loans.
32
Stock Ownership Guidelines
In March 2017, we established stock ownership guidelines applicable to our NEOs and non-employee directors. The guidelines promote share ownership by requiring NEOs and non-employee directors to attain and maintain a minimum share ownership level equal to a multiple of his or her base salary or annual cash retainer. The required ownership levels under the guidelines are as follows:
Position |
Ownership Requirement | |
Chief Executive Officer |
5x Annual Base Salary | |
Other Executive Officers |
3x Annual Base Salary | |
Non-Employee Director |
5x Annual Cash Retainer |
Should any NEO or non-employee director not satisfy the stock ownership guidelines (as described above) such NEO or non-employee director must retain at least 50% of any net shares derived from vested restricted stock or restricted stock units, exercised stock options or stock purchase plan holdings until his or her guideline is met. Net shares are those shares that remain after shares are sold or netted to pay the exercise price (if any) of equity awards and applicable taxes. As of January 31, 2018, all of our NEOs and non-employee directors satisfy their equity ownership requirements.
Clawback Policy
Our Board has adopted an Executive Compensation Clawback Policy. Under the policy, if we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirements under the securities laws caused by misconduct, we can seek recoupment from current or former NEOs who participated in the misconduct of an amount corresponding to any performance-based compensation (including any cash bonus or equity-based awards) that the Company determines would not have been granted, vested or paid had the Companys results as originally reported been equal to the Companys results as subsequently restated. The policy applies to incentive compensation granted for fiscal years commencing after January 31, 2017.
Accounting and Tax Considerations
Section 162(m) of the U.S. Internal Revenue Code of 1986, as amended, or the Internal Revenue Code generally disallows a tax deduction for compensation in excess of $1.0 million paid to our CEO, CFO and certain other employees including our NEOs. While the Board and our compensation committee generally consider the financial accounting and tax implications of compensation decisions, neither element has been a material consideration in the compensation awarded to our NEOs historically. To maintain flexibility in compensating our executive officers in a manner designed to achieve our corporate objectives, the Board and compensation committee do not require that all compensation be deductible.
We account for equity compensation paid to our employees under applicable accounting guidance for stock-based compensation arrangements, which requires us to estimate and record an expense over the service period of the award. Accordingly, stock-based compensation cost is measured and recorded at grant date, based on the fair value of the awards, and is recognized as an expense over the requisite employee service period.
Compensation Risk Assessment
Our compensation committee assesses and considers potential risks when considering and approving the compensation programs for our executive officers and employees. Based upon this assessment, we believe our compensation programs are structured in a manner that does not create risks reasonably likely to have a material adverse effect on us in the future. Our compensation committee retains oversight of all compensation decisions
33
relating to our executive officers. Our compensation programs are designed with features to address potential risks while rewarding employees and executives for achieving financial and corporate objectives. The primary component of executive incentive compensation is equity awards with multiple-year vesting, which are intended to encourage long-term growth and appreciation in the value of our business and reduce the incentive for executives and other employees to take risks that might increase short-term compensation at the expense of long term Company performance and results. In addition, the total amount of performance-based cash incentives is capped. Moreover, we do not offer excessive perquisites.
34
COMPENSATION COMMITTEE REPORT2
The compensation committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with Ambarellas management. Based on this review and discussion, the compensation committee has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in Ambarellas Proxy Statement.
D. Jeffrey Richardson (Chairman)
Hsaio-Wuen Hon
Chenming C. Hu
Andrew Verhalen
2 | The material in this report is not soliciting material, is not deemed filed with the SEC, and is not to be incorporated by reference into any filing by Ambarella under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, other than Ambarellas Annual Report on Form 10-K, where it shall be deemed to be furnished, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filing. |
35
Summary Compensation Table for Fiscal Year 2018
The following table summarizes the compensation that we paid or was earned by our chief executive officer, our chief financial officer and each of our three most highly compensated executive officers during the 2018 fiscal year ended January 31, 2018. We refer to these executive officers in this proxy statement as our named executive officers (or NEOs).
Name and Principal Position |
Fiscal Year |
Salary ($) | Option Awards ($)(1) |
Stock Awards ($)(1)(2) |
Non-Equity Incentive Plan Compensation ($)(3) |
All Other Compensation ($)(4) |
Total ($) | |||||||||||||||||||||
Feng Ming (Fermi) Wang, |
2018 | 340,000 | | 4,564,044 | 160,000 | | 5,064,044 | |||||||||||||||||||||
Chairman of the Board of Directors, President and Chief Executive Officer |
|
2017 2016 |
|
|
340,000 340,000 |
|
|
807,385 |
(5)
|
|
5,367,941 |
|
|
604,495 625,000 |
|
|
|
|
|
1,751,880 6,332,941 |
| |||||||
Leslie Kohn |
2018 | 320,000 | | 2,129,266 | 160,000 | 13,500 | 2,622,766 | |||||||||||||||||||||
Chief Technology Officer and Director |
|
2017 2016 |
|
|
320,000 320,000 |
|
|
|
|
|
2,561,414 |
|
|
296,752 292,000 |
|
|
5,000 9,000 |
|
|
621,752 3,182,414 |
| |||||||
George Laplante, |
2018 | 320,000 | | 1,714,820 | 155,000 | 32,784 | 2,222,604 | |||||||||||||||||||||
Chief Financial Officer(6) |
|
2017 2016 |
|
|
320,000 320,000 |
|
|
|
|
|
2,451,135 |
|
|
263,780 290,000 |
|
|
32,784 |
|
|
616,564 3,061,135 |
| |||||||
Yun-Lung (Michael) Chen |
2018 | 232,350 | (7) | | 757,422 | 80,000 | | 1,069,772 | ||||||||||||||||||||
Vice President, Business Development |
|
2017 2016 |
|
|
208,900 234,000 |
|
|
|
|
|
1,017,213 |
|
|
140,683 158,000 |
|
|
|
|
|
349,583 1,409,213 |
| |||||||
Christopher Day |
2018 | 245,000 | | 714,527 | 80,000 | 2,000 | 1,041,527 | |||||||||||||||||||||
Vice President, Marketing and Business Development |
|
2017 2016 |
|
|
245,000 245,000 |
|
|
|
|
|
876,259 |
|
|
136,286 148,000 |
|
|
3,000 4,000 |
|
|
384,286 1,273,259 |
|
(1) | The dollar amounts in this column do not reflect dollar amounts actually received by our NEOs. Instead, these amounts represent the aggregate full grant date fair value calculated in accordance with FASB ASC Topic 718 for equity awards granted during the fiscal years ended January 31, 2018, 2017 and 2016. Stock option awards are valued using the Black Scholes option valuation model and the assumptions outlined in Note 11 of our financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2018, as filed with the SEC on March 30, 2018. |
(2) | The dollar amounts in this column include aggregate grant date fair values of the PRSUs granted in fiscal year 2018, calculated pursuant to FASB ASC 718. The grant date fair values of the PRSUs were calculated based on the application of a Monte Carlo simulation model to determine the probable outcomes of the market-based performance conditions. The grant date fair values of the PRSUs do not correspond to the actual values that may be recognized by the holders of these awards, which may be higher or lower based on a number of factors, including Ambarellas performance, the performance of the companies included in the Philadelphia Semiconductor Index, and the satisfaction of other applicable vesting conditions. Since certain vesting conditions related to the PRSUs are considered market conditions and not performance conditions pursuant to FASB ASC 718, maximum grant date fair values are not provided in this column. The vesting conditions and other terms of the PRSUs are discussed in more detail in the tables entitled Grants of Plan-Based Awards in Fiscal Year 2018 and Outstanding Equity Awards at 2018 Fiscal Year End and in Compensation Discussion and Analysis. |
36
The table below sets forth the maximum grant date fair values of the PRSUs granted to Ambarellas NEOs in fiscal year 2018 assuming all performance conditions are achieved at maximum levels:
Name |
Shares | PRSU Awards Per Share ($) |
Aggregate Value ($) |
|||||||||
Fermi Wang |
49,296 | 55.80 | 2,750,717 | |||||||||
Leslie Kohn |
13,999 | 55.80 | 781,144 | |||||||||
George Laplante |
11,274 | 55.80 | 629,089 | |||||||||
Michael Chen |
4,980 | 55.80 | 277,884 | |||||||||
Christopher Day |
4,731 | 55.80 | 263,990 |
(3) | Reflects performance-based cash bonuses paid to our executive officers for performance for the fiscal years ended January 31, 2018, 2017 and 2016. |
(4) | Reflects payments made under our patent incentive program to Mr. Kohn and Mr. Day. Reflects payments made to Mr. Laplante for housing expense associated with an apartment rental located near the Companys offices in Santa Clara, CA. |
(5) | The stock option award was granted in fiscal year 2017 but was intended to compensate for fiscal year 2016 performance. |
(6) | Mr. Laplante intends to retire in 2018, and the Company has initiated a search for his replacement. Mr. Laplante plans to remain in his current role until a successor is named and an orderly transition is completed. |
(7) | Mr. Chen is paid in Taiwan. His base salary for fiscal year 2018 remained consistent in Taiwan dollars with his base salary for fiscal years 2016 and 2017. |
Grants of Plan-Based Awards for Fiscal Year 2018
The following table shows, for each of the NEOs, certain information concerning all plan-based awards made in fiscal year ended January 31, 2018. This information supplements the information about these awards set forth in the Summary Compensation Table.
Estimated Possible Payout |
Estimated Future Payouts |
All Other Stock Awards: Number of Shares of Stock or Units (#) |
Grant Date Fair Value of Stock and Option Awards ($)(3) |
|||||||||||||||||||||||||||||||||
Name |
Grant Date | Threshold ($)(1) |
Target ($)(1) |
Maximum ($)(1) |
Threshold (#)(2) |
Target (#)(2) |
Maximum (#)(2) |
|||||||||||||||||||||||||||||
Fermi Wang |
0 | 591,000 | 797,000 | |||||||||||||||||||||||||||||||||
3/28/2017 | 0 | 39,437 | 69,015 | 2,363,459 | ||||||||||||||||||||||||||||||||
3/28/2017 | 39,437 | (4) | 2,200,585 | |||||||||||||||||||||||||||||||||
Leslie Kohn |
0 | 290,000 | 391,000 | |||||||||||||||||||||||||||||||||
3/28/2017 | 0 | 11,199 | 19,598 | 671,156 | ||||||||||||||||||||||||||||||||
3/28/2017 | 26,131 | (5) | 1,458,110 | |||||||||||||||||||||||||||||||||
George Laplante |
0 | 258,000 | 348,000 | |||||||||||||||||||||||||||||||||
3/28/2017 | 0 | 9,019 | 15,783 | 540,509 | ||||||||||||||||||||||||||||||||
3/28/2017 | 21,045 | (5) | 1,174,311 | |||||||||||||||||||||||||||||||||
Michael Chen |
0 | 138,000 | 186,000 | |||||||||||||||||||||||||||||||||
3/28/2017 | 0 | 3,984 | 6,972 | 238,761 | ||||||||||||||||||||||||||||||||
3/28/2017 | 9,295 | (5) | 518,661 | |||||||||||||||||||||||||||||||||
Christopher Day |
0 | 133,000 | 180,000 | |||||||||||||||||||||||||||||||||
3/28/2017 | 0 | 3,785 | 6,624 | 225,217 | ||||||||||||||||||||||||||||||||
3/28/2017 | 8,769 | (5) | 489,310 |
37
(1) | Our non-equity incentive plan awards, and how they were determined, are based upon a structure that includes some discretion as to amounts paid to each NEO, as discussed above in the Compensation Discussion and Analysis. The amounts listed in this table represent the threshold, target and maximum amounts that would have been earned under the Fiscal Year 2018 Annual Bonus Plan assuming each NEO received the percentage of the bonus pool that was awarded to the individual for fiscal year 2017. The actual percentage of the bonus pool allocated to each individual was determined following completion of fiscal year 2018 based on a variety of factors, including historical allocation, the executives individual contributions and retention considerations, as well as taking into consideration the CEOs recommendations. No amounts are earned for failure to achieve either of the threshold revenue and operating profit before bonus goals. Actual amounts paid out to the executive officers under the Fiscal Year 2018 Annual Bonus Plan are included in the Summary Compensation Table above. |
(2) | The amounts shown represent shares potentially issuable pursuant to performance-based restricted stock units (or PRSUs) granted on March 28, 2017, under our 2012 Equity Incentive Plan. These awards have both performance and continued service conditions that must be met in order for the executive to receive the shares. In February 2018, the Board determined that the fiscal year 2018 strategic criteria had been satisfied at a level that resulted in the target number of shares becoming eligible for time-based vesting. Pursuant to the time-based vesting requirements, the target number of shares underlying the equity awards is scheduled to vest on March 15, 2020, subject to continued service through the scheduled vesting date. In addition, the number of underlying shares eligible to vest on March 15, 2020, may be increased or decreased by 25% of target or may remain the same, based on attainment of specified levels of the Companys total stockholder return (TSR) over the three-year period ending January 31, 2020. The maximum level represents the best case TSR performance scenario and assuming all of the fiscal year 2018 strategic criteria had been satisfied. |
(3) | The dollar amounts in this column do not reflect dollar amounts actually received by our NEOs. Instead, these amounts represent the aggregate full grant date fair value calculated in accordance with FASB ASC Topic 718. |
(4) | Represents a restricted stock unit grant vesting quarterly over a period of two years, subject to continued service through the applicable vesting dates. |
(5) | Represents a restricted stock unit grant vesting quarterly over a period of two and one-half years, subject to continued service through the applicable vesting dates. |
Option Exercises and Stock Vested During Fiscal Year 2018
The following table shows certain information concerning option exercises and value realized upon the exercise of stock options and the vesting of restricted stock unit grants by the NEOs during fiscal year 2018.
Option Awards | Stock Awards | |||||||||||||||
Name |
Number of Shares Acquired on Exercise (#) |
Value Realized on Exercise ($)(1) |
Number of Shares Acquired on Vesting (#) |
Value Realized on Vesting ($)(2) |
||||||||||||
Fermi Wang |
| | 77,776 | $ | 3,992,926 | |||||||||||
Leslie Kohn |
| | 42,788 | $ | 2,194,237 | |||||||||||
George Laplante |
| | 37,542 | $ | 1,927,988 | |||||||||||
Michael Chen |
| | 16,307 | $ | 836,594 | |||||||||||
Christopher Day |
1,071 | $ | 49,994 | 14,040 | $ | 720,178 |
(1) | The value realized on exercise is calculated as the difference between the market price of the shares underlying the options exercised and the applicable exercise price of those options. |
(2) | The value realized on vesting is calculated by multiplying the number of shares of stock by the market value of the underlying shares on each vesting date. |
38
Outstanding Equity Awards at Fiscal Year-End 2018
The following table shows certain information regarding outstanding equity awards held by our NEOs at the end of fiscal year 2018.
Option Awards | Stock Awards | |||||||||||||||||||||||
Name |
Number of Securities Underlying Unexercised Options (#) Exercisable (1) |
Number of Securities Underlying Unexercised Options (#) Unexercisable (1) |
Option Exercise Price ($) |
Option Expiration Date |
Number of Shares or Units of Stock That Have Not Vested (#) |
Market Value of Shares or Units of Stock That Have Not Vested ($)(2) |
||||||||||||||||||
Fermi Wang |
104,444 | | $ | 2.93 | 7/9/2018 | |||||||||||||||||||
111,110 | | $ | 6.62 | 10/28/2019 | ||||||||||||||||||||
66,666 | | $ | 8.82 | 11/02/2020 | ||||||||||||||||||||
44,444 | | $ | 8.82 | 8/29/2021 | ||||||||||||||||||||
30,000 | 6,000 | (3) | $ | 38.92 | 9/7/2024 | |||||||||||||||||||
26,190 | 23,810 | (4) | $ | 41.36 | 3/06/2026 | |||||||||||||||||||
15,750 | (5) | $ | 793,800 | |||||||||||||||||||||
13,125 | (6) | $ | 61,500 | |||||||||||||||||||||
32,792 | (7) | $ | 1,652,717 | |||||||||||||||||||||
24,649 | (8) | $ | 1,242,310 | |||||||||||||||||||||
39,437 | (9) | $ | 1,987,625 | |||||||||||||||||||||
Leslie Kohn |
4,445 | | $ | 8.82 | 8/29/2021 | |||||||||||||||||||
17,000 | 3,400 | (3) | $ | 38.92 | 9/7/2024 | |||||||||||||||||||
8,925 | (5) | $ | 449,820 | |||||||||||||||||||||
6,278 | (6) | $ | 316,411 | |||||||||||||||||||||
15,683 | (7) | $ | 790,423 | |||||||||||||||||||||
18,292 | (10) | $ | 921,917 | |||||||||||||||||||||
11,199 | (9) | $ | 564,430 | |||||||||||||||||||||
George Laplante |
34,912 | | $ | 8.82 | 3/7/2021 | |||||||||||||||||||
3,148 | | $ | 8.82 | 8/29/2021 | ||||||||||||||||||||
16,250 | 3,250 | (3) | $ | 38.92 | 9/7/2024 | |||||||||||||||||||
8,532 | (5) | $ | 430,013 | |||||||||||||||||||||
5,992 | (6) | $ | 301,997 | |||||||||||||||||||||
14,970 | (7) | $ | 754,488 | |||||||||||||||||||||
14,732 | (10) | $ | 742,493 | |||||||||||||||||||||
9,019 | (9) | $ | 454,558 | |||||||||||||||||||||
Michael Chen |
2,037 | | $ | 3.20 | 7/08/2019 | |||||||||||||||||||
5,555 | | $ | 8.82 | 11/02/2020 | ||||||||||||||||||||
8,289 | | $ | 8.82 | 8/29/2021 | ||||||||||||||||||||
5,241 | | $ | 9.99 | 7/9/2022 | ||||||||||||||||||||
4,637 | 1,326 | (3) | $ | 38.92 | 9/7/2024 | |||||||||||||||||||
3,479 | (5) | $ | 175,342 | |||||||||||||||||||||
2,473 | (6) | $ | 124,639 | |||||||||||||||||||||
6,178 | (7) | $ | 311,371 | |||||||||||||||||||||
6,507 | (10) | $ | 327,953 | |||||||||||||||||||||
3,984 | (9) | $ | 200,793 | |||||||||||||||||||||
Christopher Day |
2,200 | 1,100 | (3) | $ | 38.92 | 9/7/2024 | ||||||||||||||||||
2,888 | (5) | $ | 145,555 | |||||||||||||||||||||
2,140 | (6) | $ | 107,856 | |||||||||||||||||||||
5,347 | (7) | $ | 269,489 | |||||||||||||||||||||
6,139 | (10) | $ | 309,406 | |||||||||||||||||||||
3,758 | (9) | $ | 189,403 |
39
(1) | Vesting of each equity award pursuant to the vesting schedules described in the footnotes to the above table is contingent upon the executive officers continued service to the Company through the applicable vesting dates. |
(2) | The amounts under Market Value of Shares of Stock or Units That Have Not Vested were calculated as the product of the closing price of our ordinary shares on the NASDAQ Global Market on January 31, 2018, which was $50.40, and the number of shares subject to the applicable stock option or restricted stock unit award. |
(3) | The shares subject to the stock option are scheduled to vest over a four-year period commencing on September 8, 2014, with 1/48 of the shares vesting on a monthly basis. |
(4) | The shares subject to the stock option are scheduled to vest over a three and one-half year period commencing on March 15, 2016, with 1/42 of the shares vesting on a monthly basis. |
(5) | The shares subject to the restricted stock unit grant are scheduled to vest over a four-year period commencing on September 15, 2014, with 1/16 of the shares vesting on a quarterly basis. |
(6) | The shares subject to the restricted stock unit grant are scheduled to vest over a four-year period commencing on September 15, 2015, with 1/16 of the shares vesting on a quarterly basis. |
(7) | The shares subject to each restricted stock award are scheduled to vest over a three and one-half year period commencing on March 15, 2016, with 1/14 of the shares vesting on a quarterly basis. |
(8) | The shares subject to the restricted stock unit award are scheduled to vest over a two year period commencing on March 15, 2017, with 1/8 of the shares vesting on a quarterly basis. |
(9) | Shares represent an award of performance-based restricted stock units covering a target number of shares. Pursuant to time-based vesting requirements, 100% of this portion of the award is scheduled to vest on March 15, 2020, subject to continued service requirements. The number of shares eligible to vest on March 15, 2020 may be increased or decreased by 25% or may remain the same, based on attainment of specified levels of the Companys total stockholder return over the three-year period ending January 31, 2020. |
(10) | The shares subject to the stock award are scheduled to vest over a two and one-half year period commencing on March 15, 2017, with 1/10 of the shares vesting on a quarterly basis. |
Broad Based Employee Benefits
We believe that establishing competitive benefit packages for our employees is an important factor in attracting and retaining highly qualified personnel. Our NEOs are eligible to participate in all of our employee benefit plans, such as medical, dental, disability, vision, group life and accidental death and dismemberment insurance, our patent incentive program and our 401(k) plan, in each case on the same basis as other U.S.-based salaried employees. Mr. Chen is based in Taiwan and as a result, he participates in the generally available employee benefit plans maintained for our Taiwan employees. We do not offer club memberships, automobile allowances, tickets to sporting events or concerts or other perquisites to any of our NEOs as that would be inconsistent with our egalitarian corporate culture.
Pension Benefits
Aside from our 401(k) plan, we do not maintain any pension plan or arrangement under which our NEOs are entitled to participate or receive post-retirement benefits.
Non-Qualified Deferred Compensation
We do not maintain any nonqualified deferred compensation plans or arrangements under which our NEOs are entitled to participate.
40
Potential Payments upon Termination or Change in Control
Severance Arrangements
We have entered into change of control and severance agreements with Dr. Wang and Messrs. Laplante, Kohn and Day. Pursuant to such agreements, upon a termination of an NEO by us other than for cause occurring more than three months before or twelve months following a change of control, subject to the execution of a general release of claims, such NEO is entitled to:
| the payment of accrued salary and vacation; |
| payment of a lump sum equal to 100% (Dr. Wang and Messrs. Laplante and Kohn) or 50% (Mr. Day) of the executive officers then-current annual base salary; |
| payment of a prorated portion of the executive officers annual target bonus; |
| immediate acceleration of twelve months (Dr. Wang and Messrs. Laplante and Kohn) or six months (Mr. Day) of vesting of outstanding options and restricted stock unit (RSU) awards; however, the award agreement governing the performance-based restricted stock units modify this treatment with respect to such awards, as described below; and |
| Company-paid premiums for COBRA continuation coverage for up to twelve months (Dr. Wang and Messrs. Laplante and Kohn) or six months (Mr. Day) after the date of termination. |
Change of Control Arrangements
Pursuant to the change of control and severance agreements, upon a termination of an NEO (other than Mr. Chen) by us other than for cause or, if such officer resigns for good reason, within three months before or twelve months following a change of control, subject to the execution of a general release of claims, our NEOs are entitled to:
| the payment of accrued salary and vacation; |
| payment of a lump sum equal to 100% of the executive officers then-current annual base salary; |
| payment of a prorated portion of the executive officers annual target bonus; |
| immediate acceleration of vesting of 100% (Dr. Wang and Messrs. Laplante and Kohn) or 50% (Mr. Day) of outstanding options and RSU awards; however, the award agreement governing the performance-based restricted stock units modify this treatment with respect to such awards, as described below; and |
| Company-paid premiums for COBRA continuation coverage for up to twelve months after the date of termination. |
Severance Upon Death or Disability
Pursuant to the change of control and severance agreements, if the NEO terminates due to the NEOs death or disability (as defined in the agreements) subject to the execution of a general release of claims, such NEO is entitled to payment of a lump sum equal to 100% of the executive officers then-current annual base salary. With respect to Mr. Day only, this amount is reduced to 50% of his then-current annual base salary if such termination occurs more than three months before or twelve months following a change of control.
In addition to the foregoing benefits, Dr. Wang and Messrs. Laplante and Kohn also would receive a gross-up payment if such officer is required to pay excise tax under Section 4999 of the Code, with the amount of such gross-up payment equal to the amount of excise tax. No other executive would receive a gross-up payment. In the event that the severance and other benefits payable to Mr. Day constitute parachute payments under Section 280G of the Code and would be subject to the excise tax imposed by Section 4999 of the Code, then such executives benefits will be either (i) delivered in full or (ii) delivered to such lesser extent which would result in no portion of such benefits being subject to the excise tax, whichever results in the receipt by such executive on an after-tax basis of the greatest amount of benefits.
41
For purposes of the change of control and severance agreements above, the term cause generally means the occurrence of any of the following events: (i) the executive officers willful and continued failure to substantially perform the duties of his position (other than failure resulting from the executive officers complete or partial incapacity due to physical or mental illness or impairment); (ii) the executive officers willful and continued failure to substantially perform the lawful and specific directives of the Board, as reasonably determined by the Board (other than failure resulting from the executive officers complete or partial incapacity due to physical or mental illness or impairment); (iii) the executive officers willful commission of an act of fraud or dishonesty resulting in, or is likely to result in, material economic or financial injury to us; or (iv) the executive officers willful engagement in illegal conduct that was or is reasonably likely to be materially injurious to us; provided that we have provided to the executive officer any requisite notice in a timely manner and, if permitted to correct the deficiency, the executive officer has failed to do so.
For purposes of the change of control and severance agreements above, change of control generally means the occurrence of any of the following events: (i) any person acquires ownership of our securities representing more than 50% of the total voting power of our stock (except that any change in the ownership of our ordinary shares as a result of a private financing that is approved by the Board will not be considered a change of control); (ii) any person acquires 50% or more of the total gross fair market value of our assets over a twelve-month period; (iii) the consummation of our merger or consolidation with any other entity, other than a merger or consolidation that would result in our voting securities outstanding immediately prior thereto continuing to represent more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the Board or other governing body of such surviving entity; or (iv) the replacement of a majority of the Board during any twenty-four month period by directors whose appointment or election is not approved by a majority of the members of the Board prior to the date of the appointment or election.
For purposes of the change of control and severance agreements above, good reason generally means the executive officers voluntary resignation from all positions such officer holds with us, effective within 90 days following the expiration of the cure period described below, after the occurrence of any of the following without the NEOs written consent: (i) a reduction by us of the executive officers base salary or annual target bonus in effect immediately prior to such reduction (other than reductions in connection with similar percentage reductions imposed on all executive-level employees); (ii) a reduction by us of the executive officers health or welfare benefits in effect immediately prior to such reduction (other than reductions in connection with similar percentage reductions imposed on all executive-level employees); (iii) our requiring the executive officer to move his primary work location to a location that increases his one-way commute by more than 30 miles from our then-current location; (iv) our failure to continue in effect any material compensation or benefit plan or practice in which the executive officer is eligible to participate in immediately prior to the change of control; (v) our failure to obtain the assumption, in all material respects, of the change of control agreement by any of our successors; or, for certain of the executive officers, (vi) a material diminution in such executive officers authority, duties, responsibilities, title or reporting structure, provided that a material diminution in the executive officers title or reporting structure solely by virtue of the Company being acquired and made part of a larger entity will not by itself be sufficient to constitute good reason. In all cases, the executive officer must provide written notice to us of the existence of one of these conditions within 60 days after its initial existence, and we must be provided with a period of 30 days during which we may cure the circumstances giving rise to the condition, in which case no good reason will exist.
Performance-Based Restricted Stock Units
In the event of our change in control, as defined in our 2012 Equity Incentive Plan, the following treatment would occur with respect to the strategic goals under the PRSU awards. If the change in control had occurred before the last day of fiscal year 2018, the target number of shares underlying the PRSUs would have become eligible to vest, or if all three strategic goals under the PRSUs already had been achieved, then 150% of the target number of shares would have become eligible to vest. If the change in control were to occur on or after the last
42
day of fiscal year 2018, then the PRSUs would become eligible to vest based on the extent to which the strategic goals actually were achieved during fiscal year 2018.
The relative TSR goal under the PRSUs would be treated as follows in the event of our change in control. If TSR has not yet been measured, then our relative TSR performance will be measured in connection with the change in control by basing our TSR performance on the merger consideration payable with respect to Company shares in connection with the change in control, and the TSR measurement period would be shortened to reflect earlier measurement as a result of the change in control. To the extent that the actual relative TSR performance would increase the number of shares underlying the PRSUs that can vest, the adjustment will be applied to the PRSUs. However, no adjustment would be made to reduce the number of shares underlying the PRSUs that can vest as a result of actual relative TSR performance. Any shares that do not become eligible to vest based on the above treatment of the performance objectives would be forfeited at the change in control, and the shares underlying the PRSUs that have become eligible to vest will be scheduled to vest on the fifteenth day of each of June, September, December and March through March 15, 2020, with the first scheduled vesting date occurring on June 15, 2017, in equal installments, subject to the executives continued service through the applicable vesting dates. Further, the portion of the PRSUs that have become eligible to vest that are outstanding as of the change in control will be treated in accordance with the terms of our 2012 Equity Incentive Plan and any change of control and severance agreement then in effect.
Further, with respect to any change of control and severance agreement in effect with respect to an NEO, if the NEOs employment had terminated before the last day of fiscal year 2018, the PRSU award would have been forfeited in its entirety and would not have been eligible for any vesting acceleration under the change of control and severance agreement. If on or after the last day of fiscal year 2018 but before March 15, 2020, the NEOs employment is terminated by us other than for cause (as defined in the change of control and severance agreement) (and other than due to the NEOs death or disability, as defined in the change of control and severance agreement) or, if he resigns for good reason (as defined in the change of control and severance agreement), and he otherwise satisfies the other requirements under the change of control and severance agreement for the payment of other severance benefits to him, then a prorated number of shares underlying the award will accelerate vesting, with respect to the portion of the award eligible to vest based on the extent to which any strategic goals have been met on or before the employment termination but during the performance period (and as adjusted by the relative TSR performance if the TSR measurement period had concluded by the employment termination date). The proration generally is determined by measuring the number of shares under the award that would have vested through the last day of the NEOs employment with us, had the award been scheduled to vest in equal, quarterly installments through March 15, 2020, with a first vesting date of June 15, 2017.
If on or after a change in control, the NEOs employment is terminated by us other than for cause (as defined in the change of control and severance agreement) (and other than due to the NEOs death or disability, as defined in the change of control and severance agreement) or if he resigns for good reason (as defined in the change of control and severance agreement), the PRSU award will be eligible for the vesting acceleration under the NEOs change of control and severance agreement then in effect (as described further above). Otherwise, the terms of the PRSU award agreement generally supersede the vesting acceleration benefits under the NEOs change of control and severance agreement.
For purposes of the PRSU awards above, change in control, as defined in our 2012 Equity Incentive Plan generally means the occurrence of any of the following events: (i) any person acquires ownership of more than 50% of the total voting power of our stock (except that acquisition of additional stock by a person already considered to own more than 50% of the voting power of our stock will not be considered a change in control); (ii) a change in our effective control that occurs when a majority of members of our Board is replaced during a 12-month period by directors whose appointment or election is not endorsed by a majority of members of the Board prior to the date of the appointment or election; or (iii) a change in ownership of a substantial portion of our assets that occurs when a person acquires 50% or more of the total gross fair market value of our assets over
43
a twelve-month period (subject to certain exceptions, such as the transfer of our assets to our stockholders in exchange for or with respect to our stock).
Potential Payments upon Termination or Change in Control
The following table summarizes the payments that would be made to our NEOs upon the occurrence of a termination of employment qualifying for severance benefits or upon a change of control, assuming that each NEOs termination of employment with our Company occurred on January 31, 2018, or in the event that a qualifying termination of employment in connection with a change of control of our Company occurred on January 31, 2018, as applicable. Amounts shown do not include (i) accrued but unpaid salary through the date of termination, or (ii) other benefits earned or accrued by the NEO during his employment that are available to all salaried employees, such as accrued vacation.
Termination Without Cause (No change of control) ($) |
Termination Without Cause (Within three months before or twelve months after change of control) ($) |
|||||||
Fermi Wang |
||||||||
Cash Severance Attributable to Salary |
$ | 340,000 | $ | 340,000 | ||||
Cash Severance Attributable to Bonus |
160,000 | 160,000 | ||||||
Acceleration of Stock Options (1) |
198,023 | 284,122 | ||||||
Acceleration of RSUs, PRSUs and Restricted Stock Awards (2) |
3,110,008 | 4,350,326 | ||||||
Continued Health Benefits (3) |
37,720 | 37,720 | ||||||
|
|
|
|
|||||
Total |
$ | 3,845,751 | $ | 5,172,168 | ||||
|
|
|
|
|||||
Leslie Kohn |
||||||||
Cash Severance Attributable to Salary |
$ | 320,000 | $ | 320,000 | ||||
Cash Severance Attributable to Bonus |
160,000 | 160,000 | ||||||
Acceleration of Stock Options (1) |
39,032 | 39,032 | ||||||
Acceleration of RSUs, PRSUs and Restricted Stock Awards (2) |
1,609,076 | 2,478,571 | ||||||
Continued Health Benefits (3) |
25,380 | 25,380 | ||||||
|
|
|
|
|||||
Total |
$ | 2,153,488 | $ | 3,022,983 | ||||
|
|
|
|
|||||
George Laplante |
||||||||
Cash Severance Attributable to Salary |
$ | 320,000 | $ | 320,000 | ||||
Cash Severance Attributable to Bonus |
155,000 | 155,000 | ||||||
Acceleration of Stock Options (1) |
37,310 | 37,310 | ||||||
Acceleration of RSUs, PRSUs and Restricted Stock Awards (2) |
1,457,986 | 2,228,990 | ||||||
Continued Health Benefits (3) |
25,380 | 25,380 | ||||||
|
|
|
|
|||||
Total |
$ | 1,995,676 | $ | 2,766,680 | ||||
|
|
|
|
|||||
Christopher Day |
||||||||
Cash Severance Attributable to Salary |
$ | 122,500 | $ | 245,000 | ||||
Cash Severance Attributable to Bonus |
80,000 | 80,000 | ||||||
Acceleration of Stock Options (1) |
9,471 | 12,628 | ||||||
Acceleration of RSUs, PRSUs and Restricted Stock Awards (2) |
293,214 | 416,153 | ||||||
Continued Health Benefits (3) |
18,860 | 37,720 | ||||||
|
|
|
|
|||||
Total |
$ | 524,045 | $ | 791,501 | ||||
|
|
|
|
(1) | The value of accelerated stock options was calculated by multiplying (x) the number of shares subject to acceleration by (y) the difference between the fair market value of an ordinary share on January 31, 2018, which was $50.40, and the per share exercise price of the unvested shares subject to acceleration. |
44
(2) | The value of accelerated RSUs, PRSUs and RSAs was calculated by multiplying (x) the number of shares subject to acceleration by (y) the fair market value of an ordinary share on January 31, 2018, which was $50.40. |
(3) | Represents the aggregate premium payments that would be required to be paid to or on behalf of the NEO to provide continued health insurance coverage under COBRA (based on the executives health insurance coverage as of January 31, 2018) for the period available to the executive. |
Pursuant to Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(u) of Regulation S-K, we are required to disclose the ratio of our principal executive officers annual total compensation to the annual total compensation of our median employee. As of January 16, 2018, the median employee determination date for fiscal year 2018, we had a total of approximately 705 employees. As of such date, approximately 22% of our employees were located in the U.S., primarily in Santa Clara, California, and 78% were located outside of the U.S., primarily in China and Taiwan.
As discussed above in the Compensation Discussion and Analysis, we are engaged in a very competitive industry, and our success depends on its ability to attract, motivate and retain highly qualified, talented and creative employees. Consistent with our executive compensation program, our global compensation program is designed to be competitive in terms of both the position and the geographic location in which an employee is located. Accordingly, our pay structures vary among our employees based on position and geographic location, with significant consideration given to local competitive market practices. We believe our compensation philosophy and process yield an equitable result for all of our employees.
Pay Ratio
During fiscal year 2018, the principal executive officer of Ambarella was our Chief Executive Officer, Dr. Feng-Ming (Fermi) Wang. For fiscal year 2018, the annual total compensation for Dr. Wang was $5,064,044, as disclosed under the Summary Compensation Table above, and the annual total compensation for our median employee was $71,477, calculated using the same methodology as applied for Dr. Wang in the Summary Compensation Table above, resulting in an estimated pay ratio of 70:1.
Identification of Median Employee
For purposes of identifying the median employee, we considered the aggregate of all the following compensation elements for each of our employees, as compiled from our internal records as of January 16, 2018:
| an estimate of the annual base salary or wages for fiscal year 2018 |
| cash bonuses or other cash incentives paid in fiscal year 2018 |
| the grant date fair value of equity awards granted in fiscal year 2018 |
We selected the above compensation elements because they represent Ambarellas principal broad-based compensation elements. For purposes of identifying the median employee, any compensation paid in foreign currencies was converted to U.S. dollars based on the average of the monthly exchange rates for the twelve-month period ended January 16, 2018. In identifying the median employee, we did not make any cost-of-living adjustments or exclude any foreign jurisdictions in accordance with Item 402(u) of Regulation S-K.
The pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our internal records and the methodology described above. Because the SEC rules for identifying the median employee and calculating the pay ratio based on that employees annual total compensation allow companies to utilize different methodologies and to make reasonable estimates and assumptions that reflect their employee populations and compensation practices, the pay ratio reported by other companies may not be comparable to the pay ratio reported above.
45
EQUITY COMPENSATION PLAN INFORMATION
The following table provides certain information with respect to all of Ambarellas equity compensation plans in effect as of January 31, 2018:
Plan Category |
Number of Securities to be Issued upon Exercise of Outstanding Options, Restricted Stock Units and Rights |
Weighted Average Exercise Price of Outstanding Options and Rights |
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans Excluding Securities Reflected in the first Column) |
|||||||||
Equity compensation plans approved by security holders: |
||||||||||||
2004 Stock Plan (1) |
814,662 | (4) | $ | 6.89 | 0 | |||||||
2012 Equity Incentive Plan (2) |
2,721,028 | (5) | $ | 42.64 | 2,025,963 | |||||||
2012 Employee Stock Purchase Plan (3) |
| $ | | 1,561,841 | ||||||||
Equity compensation plans not approved by security holders |
| $ | | | ||||||||
TOTAL: |
3,535,690 | $ | 34.40 | 3,587,804 |
(1) | Our Board of Directors adopted, and our shareholders approved, the 2004 Stock Plan, as amended, or 2004 Plan. The 2004 Plan was last amended on August 28, 2012. As a result of our initial public offering in October 2012 and the adoption of the 2012 Equity Incentive Plan at that time, we no longer grant awards under the 2004 Plan; however, all outstanding options issued pursuant to the 2004 Plan prior to our initial public offering continue to be governed by their existing terms. A total of 814,662 ordinary shares are reserved for issuance under the 2004 Plan pursuant to outstanding options. |
(2) | Our Board of Directors adopted, and our shareholders approved, the 2012 Equity Incentive Plan, or 2012 Plan, which became effective in October 2012 in connection with our initial public offering. A total of 1,104,445 ordinary shares were initially authorized for issuance under the 2012 Plan. Shares reserved for issuance under the 2004 Plan that were not subject to outstanding awards at the completion of our initial public offering or which are subject to awards granted under the 2004 Plan and subsequently expire, terminate or are forfeited to us, are added to the 2012 Plan. In addition, the 2012 Plan provides that the number of ordinary shares available for issuance under the 2012 Plan will be increased on the first day of each fiscal year beginning with the 2014 fiscal year, in an amount equal to the least of (i) 3,500,000 ordinary shares, (ii) four and one-half percent (4.5%) of the outstanding ordinary shares on the last day of the immediately preceding fiscal year or (iii) such lesser number of ordinary shares determined by the Board. |
(3) | Our Board of Directors adopted, and our shareholders approved, the 2012 Employee Stock Purchase Plan, or ESPP, which became effective in October 2012 in connection with our initial public offering. A total of 460,445 ordinary shares were initially authorized for issuance under the ESPP. The ESPP provides that the number of ordinary shares available for issuance under the ESPP will be increased on the first day of each fiscal year beginning with the 2014 fiscal year, in an amount equal to the least of (i) 1,500,000 ordinary shares, (ii) one and one-quarter percent (1.25%) of the outstanding ordinary shares on the last day of the immediately preceding fiscal year or (iii) such other amount as may be determined by the Board. |
(4) | Consists of options to purchase 814,662 shares. |
(5) | Consists of 1,924,343 shares granted as restricted stock units and options to purchase 796,685 shares. |
46
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information regarding the ownership of Ambarellas ordinary shares as of March 1, 2018 by: (i) each director and nominee for director; (ii) each of the executive officers named in the Summary Compensation Table (referred to in this Proxy Statement as our named executive officers); (iii) all executive officers and directors of Ambarella as a group; and (iv) all those known by Ambarella to be beneficial owners of more than five percent of its ordinary shares.
Beneficial Ownership (1) | ||||||||
Beneficial Owner |
Number of Shares | Percent of Total | ||||||
5% Shareholders: |
||||||||
The Vanguard Group (2) |
2,185,404 | 6.56 | % | |||||
Named Executive Officers and Directors: |
||||||||
Feng-Ming (Fermi) Wang (3) |
671,407 | 1.99 | % | |||||
Leslie Kohn (4) |
920,937 | 2.76 | % | |||||
George Laplante (5) |
151,509 | * | ||||||
Yun-Lung (Michael) Chen (6) |
46,817 | * | ||||||
Christopher Day (7) |
25,476 | * | ||||||
Chenming C. Hu (8) |
34,901 | * | ||||||
Christopher B. Paisley (9) |
34,902 | * | ||||||
D. Jeffrey Richardson (10) |
28,305 | * | ||||||
Hsaio-Wuen Hon (11) |
2,463 | * | ||||||
Andrew W. Verhalen (12) |
64,762 | * | ||||||
|
|
|
|
|||||
All executive officers and directors as a group (10 persons) (13) |
1,981,479 | 5.84 | % |
* | Less than one percent. |
(1) | This table is based upon information supplied by officers, directors and, in the case of principal shareholders, Schedules 13G filed with the SEC prior to March 1, 2018. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, Ambarella believes that each of the shareholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 33,326,899 of our ordinary shares outstanding on March 1, 2018. Beneficial ownership is determined in accordance with the rules of the SEC. In computing the number of shares beneficially owned by a person and the percentage of ownership of that person, stock options held by that person that are currently exercisable or become exercisable within 60 days of March 1, 2018 and restricted stock unit awards held by that person that are subject to release within 60 days of March 1, 2018 are considered to be outstanding and beneficially owned by such person. Those shares, however, are not deemed outstanding for the purpose of computing the percentage ownership of any other person. |
(2) | Pursuant to a Schedule 13G filed with the SEC on February 8, 2018, The Vanguard Group reported that as of December 31, 2017 it had sole voting power over 38,585 shares, shared voting power over 4,122 shares, sole dispositive power over 2,145,128 shares, and shared dispositive power over 40,276 shares, and that its principal address is 100 Vanguard Blvd., Malvern, PA 19355. |
(3) | Includes (i) 388,675 shares that Dr. Wang has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options and (ii) 10,180 shares expected to be vested and delivered pursuant to outstanding restricted stock unit awards. |
(4) | Includes (i) 22,720 shares that Mr. Kohn has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options and (ii) 5,588 shares expected to be vested and delivered pursuant to outstanding restricted stock unit awards. |
(5) | Includes (i) 55,528 shares that Mr. Laplante has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options and (ii) 4,949 shares expected to be vested and delivered pursuant to outstanding restricted stock unit awards. |
47
(6) | Includes (i) 26,256 shares that Mr. Chen has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options and (ii) 3,325 shares expected to be vested and delivered pursuant to outstanding restricted stock unit awards. |
(7) | Includes (i) 2,612 shares that Mr. Day has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options and (ii) 1,840 shares expected to be vested and delivered pursuant to outstanding restricted stock unit awards. |
(8) | Includes (i) 6,667 shares that Dr. Hu has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options, and (ii) 1,232 shares expected to be vested and delivered pursuant to an outstanding restricted stock unit award. |
(9) | Includes (i) 22,777 shares that Mr. Paisley has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options, and (ii) 1,232 shares expected to be vested and delivered pursuant to an outstanding restricted stock unit award. |
(10) | Includes (i) 16,111 shares that Mr. Richardson has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options, and (ii) 1,649 shares expected to be vested and delivered pursuant to an outstanding restricted stock unit award. |
(11) | Includes 1,232 shares expected to be vested and delivered pursuant to an outstanding restricted stock unit award. |
(12) | Includes (i) 11,110 shares that Mr. Verhalen has a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options, (ii) 1,232 shares expected to be vested and delivered pursuant to an outstanding restricted stock unit award, and (iii) 1,700 shares held in family trusts. |
(13) | Includes an aggregate of 584,915 shares that our directors and executive officers have a right to acquire within 60 days of March 1, 2018 pursuant to outstanding options and restricted stock unit awards. |
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires Ambarellas directors and executive officers, and persons who own more than ten percent of a registered class of Ambarellas equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of ordinary shares and other equity securities of Ambarella. Officers, directors and greater than ten percent shareholders are required by SEC regulation to furnish Ambarella with copies of all Section 16(a) forms they file. To Ambarellas knowledge, based solely on a review of the copies of the reports furnished to Ambarella and written representations that no other reports were required, during the fiscal year ended January 31, 2018, we believe that our officers, directors and greater than ten percent beneficial owners complied with all applicable Section 16(a) filing requirements.
48
CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS
In addition to the compensation arrangements with directors and executive officers described elsewhere in this Proxy Statement, the following is a description of each transaction since February 1, 2017 and each currently proposed transaction in which:
| Ambarella has been or is to be a participant; |
| the amount involved exceeds or will exceed $120,000; and |
| any of our directors, executive officers or beneficial holders of more than 5% of our ordinary shares, or any immediate family member of or person sharing the household with any of these individuals (other than tenants or employees), had or will have a direct or indirect material interest. |
Indemnification Agreements with Executive Officers and Directors
Ambarella has entered into indemnification agreements with each of its directors and executive officers pursuant to which Ambarella has agreed to indemnify the directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims by reason of their being such a director or officer. These indemnification agreements and Ambarellas memorandum and articles of association will indemnify each of our directors and officers to the fullest extent permitted by applicable Cayman Islands law.
License Agreements with Cadence Design Systems, Inc.
In fiscal year 2008, Ambarella entered into a master software license agreement with Cadence Design Systems, Inc., or Cadence. A former member of our Board, Lip-Bu Tan, is also the Chief Executive Officer, President and a director of Cadence. Mr. Tan departed our Board at the conclusion of his most recent term in June 2017. Our Board has noted that Mr. Tan did not derive any direct or indirect material benefit from such agreements. From time to time, Ambarella has added additional software license commitments its existing software license agreement. The Company is committed to pay an aggregate amount of $10.3 million to Cadence through November 2019.
Code of Conduct Policy and Procedures
In 2012, Ambarella adopted a formal written policy that became effective upon completion of Ambarellas initial public offering that all executive officers, directors, nominees for election as directors, beneficial owners of more than 5% of our ordinary shares and any member of the immediate family of any of the foregoing persons, are not permitted to enter into a related party transaction in which the aggregate amount involved will or may be expected exceed $120,000 in any calendar year with Ambarella without the prior consent of Ambarellas audit committee, subject to the pre-approval exceptions described below. If advance approval is not feasible, then the related party transaction will be considered at the audit committees next regularly scheduled meeting. In approving or rejecting any such proposal, the audit committee is to consider the relevant facts and circumstances including, but not limited to, whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related partys interest in the transaction. The Board has delegated to the chair of the audit committee the authority to pre-approve or ratify any request to enter into a transaction with a related party, in which the amount involved is less than $250,000 and where the chair is not the related party. The audit committee may also review certain types of related party transactions that it has deemed pre-approved even if the aggregate amount involved will exceed $120,000 including, employment of executive officers, director compensation, certain transactions with other organizations in which the relevant person is not an executive officer or beneficial owner of more than 10%, certain charitable contributions, transactions where all shareholders receive proportional benefits, transactions involving competitive bids, regulated transactions and certain banking-related services.
49
SHAREHOLDER PROPOSALS FOR THE 2019 ANNUAL MEETING OF SHAREHOLDERS
If a shareholder wishes to present a proposal to be included in our Proxy Statement for the 2019 Annual Meeting of Shareholders, the proponent and the proposal must comply with the proxy proposal submission rules of the SEC. One of the requirements is that the proposal be received by the Secretary no later than January 27, 2019. Proposals we receive after that date will not be included in the Proxy Statement. We urge shareholders to submit proposals by Certified MailReturn Receipt Requested.
A shareholder proposal not included in our proxy statement for the 2019 Annual Meeting of Shareholders will be ineligible for presentation at the 2019 Annual Meeting of Shareholders unless the shareholder gives timely notice of the proposal in writing to the Secretary of Ambarella at the principal executive offices of Ambarella. Under our articles of association, in order for a matter to be deemed properly presented by a shareholder, timely notice must be delivered to, or mailed and received by, us not more than one hundred twenty (120) days nor less than ninety (90) days in advance of the one-year anniversary of the date of our proxy statement provided in connection with the previous years Annual Meeting of shareholders, which dates are December 28, 2018 and January 27, 2019, respectively, for the 2019 Annual Meeting of Shareholders; provided, however, that in the event that we did not hold an Annual Meeting in the prior year or if the date of the Annual Meeting is more than 30 days before or after the anniversary date of the prior years Annual Meeting, we must receive the shareholders notice not earlier than the close of business on the 120th day prior to the Annual Meeting and not later than the close of business on the later of 90 days prior to the Annual Meeting and the 10th day after the day we provided such public disclosure of the meeting date.
The shareholders notice must set forth, as to each proposed matter, the following: (a) a brief description of the business desired to be brought before the meeting and reasons for conducting such business at the meeting; (b) the name and address, as they appear on our books, of the shareholder proposing such business; (c) the class and number of shares of our securities that are beneficially owned by the shareholder; (d) any material interest of the shareholder in such business; and (e) any other information that is required to be provided by such shareholder pursuant to our articles of association or the proxy proposal submission rules of the SEC. The presiding officer of the meeting may refuse to acknowledge any matter not made in compliance with the foregoing procedure.
50
HOUSEHOLDING OF PROXY MATERIALS
To reduce the expense of delivering duplicate proxy materials to shareholders who may have more than one account holding ordinary shares of Ambarella but who share the same address, we have adopted a procedure approved by the SEC called householding. Under this procedure, certain shareholders of record who have the same address and last name will receive only one copy of the Notice of Internet Availability for our proxy materials until such time as one or more of these shareholders notifies us that they want to receive separate copies. This procedure reduces duplicate mailings and saves printing costs and postage fees, as well as natural resources. Shareholders who participate in householding will continue to have access to and utilize separate proxy voting instructions.
If you receive a single copy of the Notice of Internet Availability as a result of householding, and you would like to have separate copies mailed to you or if you receive multiple copies and would like to receive a single copy, please submit a request to Corporate Secretary, Ambarella, Inc., 3101 Jay Street, Santa Clara, California 95054 or make a request by e-mail at ir@ambarella.com, and we will promptly send you what you have requested. Shareholders who hold shares in street name may contact their brokerage firm, bank, broker-dealer or other similar organization to request information about householding.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 6, 2018
The notice of annual meeting, proxy statement and annual report are available at www.edocumentview.com/AMBA. If you are a shareholder of record, you also may view these materials at http://www.envisionreports.com/AMBA.
The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.
By Order of the Board of Directors
MICHAEL MOREHEAD
General Counsel and Secretary
April 27, 2018
51
Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. X 02TQ4B 1 U PX + PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. Annual Meeting Proxy Card . B Authorized Signatures This section must be completed for your vote to be counted. Date and Sign Below Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Date (mm/dd/yyyy) Please print date below. Signature 1 Please keep signature within the box. Signature 2 Please keep signature within the box. + A Proposals The Board of Directors recommends a vote FOR all listed nominees, and a vote FOR Proposals 2 and 3. 2. Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Ambarella, Inc.s independent registered public accounting firm for the fiscal year ending on January 31, 2019. 01Hsiao-Wuen Hon, Ph.D. 02Christopher B. Paisley 1. Election of Directors: For Withhold For Withhold IMPORTANT ANNUAL MEETING INFORMATION For Against Abstain For Against Abstain 3. To approve, on an advisory basis, the compensation of Ambarella, Inc.s named executive officers. 03Andrew W. Verhalen For Withhold MMMMMMMMMMMM 3 7 3 6 9 4 2 MMMMMMMMM
PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. . Notice of 2018 Annual Meeting of Shareholders 3101 Jay Street, Santa Clara, CA 95054 Proxy Solicited by Board of Directors for Annual Meeting June 6, 2018 Feng-Ming (Fermi) Wang, George Laplante and Michael Morehead, or any of them, each with the power of substitution, are hereby authorized to represent and vote the shares of the undersigned, with all the powers which the undersigned would possess if personally present, at the Annual Meeting of Shareholders of Ambarella, Inc. to be held on June 6, 2018 at 9:00 am Pacific Time, or at any postponement or adjournment thereof. This proxy, when properly executed, will be voted in the same manner directed herein. If no such direction is made, this proxy will be voted in accordance with the boards recommendations on the reverse side. In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting. (Items to be voted appear on reverse side.) Proxy Ambarella, Inc.